| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | MED14 FOXA1 JARID2 YAP1 NKX2-2 CRTC3 TCF12 RARB HDAC5 APBB1 CRTC1 TACC2 RUNX1T1 RUNX3 HDAC7 PARP10 HEY1 BAZ2A IGHMBP2 SORBS3 NKX2-5 MYOCD ELK1 DOT1L PBX1 PROX1 | 1.06e-07 | 753 | 210 | 26 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZBTB20 DDN HIC2 FOXA1 HOXA2 NFE2L1 YAP1 NFIB UBP1 GLI2 NKX2-2 DLX6 POU2F3 KDM6A IKZF3 TCF12 RARB HDAC5 POU2F2 REL RUNX3 SOX13 TFAP2C TFE3 HEY1 SP9 NKX2-5 ELK1 SNAPC4 PBX1 ST18 PROP1 PROX1 | 8.36e-07 | 1244 | 210 | 33 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MED14 FOXA1 YAP1 CRTC3 TCF12 RARB HDAC5 APBB1 CRTC1 TACC2 RUNX1T1 HDAC7 PARP10 HEY1 BAZ2A NKX2-5 MYOCD ELK1 DOT1L PBX1 PROX1 | 9.59e-07 | 582 | 210 | 21 | GO:0140297 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZBTB20 DDN HIC2 FOXA1 HOXA2 NFE2L1 YAP1 NFIB UBP1 GLI2 NKX2-2 DLX6 POU2F3 KDM6A IKZF3 TCF12 RARB HDAC5 POU2F2 REL RUNX3 SOX13 TFAP2C TFE3 HEY1 SP9 NKX2-5 ELK1 SNAPC4 PBX1 ST18 PROP1 PROX1 | 1.34e-06 | 1271 | 210 | 33 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZBTB20 DDN HIC2 FOXA1 HOXA2 NFE2L1 YAP1 NFIB UBP1 GLI2 ZBTB5 NKX2-2 DLX6 POU2F3 KDM6A IKZF3 TCF12 RARB HDAC5 DUX4L9 POU2F2 REL RUNX3 SOX13 TFAP2C TFE3 HEY1 SP9 NKX2-5 ELK1 SNAPC4 PBX1 ST18 PROP1 PROX1 | 3.68e-06 | 1459 | 210 | 35 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZBTB20 DDN HIC2 FOXA1 HOXA2 NFE2L1 NFIB UBP1 GLI2 ZBTB5 NKX2-2 DLX6 POU2F3 IKZF3 TCF12 RARB HDAC5 DUX4L9 POU2F2 REL RUNX3 SOX13 TFAP2C TFE3 RLF HEY1 SP9 NKX2-5 ELK1 PBX1 ST18 PROP1 PROX1 | 1.25e-05 | 1412 | 210 | 33 | GO:0000981 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CNKSR1 RIPK1 MAML1 MED14 MAGI2 FBXO38 JARID2 YAP1 RPTOR BRD1 TNS3 ZCCHC12 SH3RF1 HDAC5 SYNM DOK7 APBB1 RUNX1T1 HDAC7 AKAP12 LGALS3 HIPK3 PARP10 BAZ2A DYRK1B MYOCD ELK1 DOT1L CAPRIN1 | 1.30e-05 | 1160 | 210 | 29 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXA1 NFE2L1 NFIB UBP1 GLI2 NKX2-2 POU2F3 IKZF3 TCF12 POU2F2 REL TFAP2C TFE3 RLF NKX2-5 ELK1 PBX1 PROP1 | 2.80e-05 | 560 | 210 | 18 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXA1 NFE2L1 NFIB UBP1 GLI2 NKX2-2 POU2F3 IKZF3 TCF12 POU2F2 REL TFAP2C TFE3 RLF NKX2-5 ELK1 PBX1 PROP1 | 3.22e-05 | 566 | 210 | 18 | GO:0001216 |
| GeneOntologyMolecularFunction | molecular adaptor activity | CNKSR1 RIPK1 MAML1 MED14 SGK3 MAGI2 FBXO38 JARID2 YAP1 RPTOR BRD1 TNS3 ZCCHC12 SH3RF1 HDAC5 SYNM DOK7 APBB1 RUNX1T1 HDAC7 AKAP12 LGALS3 HIPK3 PARP10 BAZ2A DYRK1B MYOCD ELK1 DOT1L CAPRIN1 | 8.86e-05 | 1356 | 210 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | vinculin binding | 3.03e-04 | 13 | 210 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | AGFG1 PLCB1 TNS3 WASL RAP1GAP RASGRF2 RGL3 ARHGEF25 ARHGAP4 ARFGAP2 PLEKHG6 TIAM1 FARP1 ARFGAP1 RAPGEF2 | 3.22e-04 | 507 | 210 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | AGFG1 PLCB1 TNS3 WASL RAP1GAP RASGRF2 RGL3 ARHGEF25 ARHGAP4 ARFGAP2 PLEKHG6 TIAM1 FARP1 ARFGAP1 RAPGEF2 | 3.22e-04 | 507 | 210 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZBTB20 HIC2 HOXA2 NFE2L1 ZBTB5 HDAC5 SOX13 TFAP2C HEY1 PROP1 PROX1 | 6.02e-04 | 320 | 210 | 11 | GO:0001227 |
| GeneOntologyMolecularFunction | beta-1 adrenergic receptor binding | 6.51e-04 | 4 | 210 | 2 | GO:0031697 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZBTB20 HIC2 HOXA2 NFE2L1 ZBTB5 HDAC5 SOX13 TFAP2C HEY1 PROP1 PROX1 | 7.01e-04 | 326 | 210 | 11 | GO:0001217 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | XIRP1 MAP4 TTLL5 TOGARAM1 ADGRV1 FMNL2 MAGI2 MYO3B DMD WASL MYOT SYNM KIF26B TOGARAM2 APBB1 SHROOM1 TIAM1 FARP1 SORBS3 SNTG2 MARK2 TNS1 PALLD | 1.31e-03 | 1099 | 210 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | MED14 FOXA1 RARB HDAC5 TACC2 HEY1 BAZ2A NKX2-5 MYOCD ELK1 DOT1L PROX1 | 1.60e-03 | 417 | 210 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | protein serine kinase activity | RIPK1 NEK10 SPEG SGK3 MAST4 MYO3B HIPK3 DYRK1B MARK2 MAP2K5 ALPK2 | 1.67e-03 | 363 | 210 | 11 | GO:0106310 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | RIPK1 MCIDAS MAML1 MED14 DDN RNF40 FOXA1 HOXA2 NFE2L1 YAP1 NFIB UBP1 GLI2 NKX2-2 POU2F3 KDM6A CRTC3 WASL IKZF3 ZCCHC12 TCF12 RARB HDAC5 APBB1 ZNF407 POU2F2 CRTC1 REL TFAP2C TFE3 RLF HEY1 NKX2-5 MYOCD ELK1 DOT1L PBX1 MAP2K5 ST18 PROP1 PROX1 | 5.61e-10 | 1390 | 210 | 41 | GO:0045944 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | XIRP1 UBE4B SPEG MAML1 JARID2 YAP1 CACNA1G RARB HDAC5 HDAC7 EFNB2 HEY1 NKX2-5 MYOCD ALPK2 PROX1 | 6.26e-07 | 349 | 210 | 16 | GO:0014706 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZBTB20 HIC2 FOXA1 HOXA2 JARID2 ZNF469 NFE2L1 YAP1 NFIB GLI2 PLCB1 ZBTB5 MAGEB17 RARB HDAC5 APBB1 RUNX1T1 RUNX3 HDAC7 SOX13 TFAP2C PHC1 HIPK3 PARP10 HEY1 BAZ2A IGHMBP2 SORBS3 NKX2-5 CIPC MYOCD MAP2K5 ST18 PROP1 PROX1 | 6.84e-07 | 1399 | 210 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZBTB20 HIC2 FOXA1 HOXA2 JARID2 ZNF469 NFE2L1 YAP1 NFIB GLI2 PLCB1 ZBTB5 MAGEB17 RARB HDAC5 APBB1 RUNX1T1 RUNX3 HDAC7 SOX13 TFAP2C PHC1 HIPK3 PARP10 HEY1 BAZ2A IGHMBP2 SORBS3 NKX2-5 CIPC MYOCD MAP2K5 ST18 PROP1 PROX1 | 8.61e-07 | 1413 | 210 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZBTB20 HIC2 FOXA1 HOXA2 JARID2 ZNF469 NFE2L1 YAP1 NFIB GLI2 ZBTB5 MAGEB17 RARB HDAC5 APBB1 RUNX3 HDAC7 SOX13 TFAP2C HIPK3 HEY1 IGHMBP2 SORBS3 NKX2-5 MYOCD MAP2K5 ST18 PROP1 PROX1 | 1.06e-06 | 1053 | 210 | 29 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | FOXA1 HOXA2 GLI2 NKX2-2 DMD RAP1GAP TCF12 APBB1 TIAM1 HEY1 NKX2-5 PBX1 PROX1 | 2.28e-06 | 255 | 210 | 13 | GO:0045664 |
| GeneOntologyBiologicalProcess | neuron development | UBE4B MAP4 ADGRV1 PRAG1 HOXA2 MAGI2 FBXO38 PTPRG NFIB GLI2 MYO3B DMD WASL MYOT SAMD4B SH3GL2 APBB1 CRTC1 SLITRK3 RUNX3 ARHGEF25 MICALL1 ARHGAP4 DZANK1 EFNB2 TIAM1 HEY1 FARP1 RP1L1 MARK2 RAPGEF2 PBX1 CAPRIN1 PALLD | 5.13e-06 | 1463 | 210 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | XIRP1 UBE4B SPEG MAML1 JARID2 YAP1 CACNA1G RARB EFNB2 HEY1 NKX2-5 MYOCD ALPK2 PROX1 | 7.04e-06 | 327 | 210 | 14 | GO:0048738 |
| GeneOntologyBiologicalProcess | neuron projection development | UBE4B MAP4 ADGRV1 PRAG1 HOXA2 MAGI2 FBXO38 PTPRG NFIB GLI2 MYO3B DMD WASL MYOT SH3GL2 APBB1 CRTC1 SLITRK3 RUNX3 ARHGEF25 MICALL1 ARHGAP4 EFNB2 TIAM1 HEY1 FARP1 MARK2 RAPGEF2 CAPRIN1 PALLD | 1.82e-05 | 1285 | 210 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | osteoblast development | 3.59e-05 | 19 | 210 | 4 | GO:0002076 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 3.59e-05 | 19 | 210 | 4 | GO:0055012 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 4.96e-05 | 94 | 210 | 7 | GO:0045665 | |
| GeneOntologyBiologicalProcess | muscle tissue development | XIRP1 UBE4B SPEG MAML1 JARID2 YAP1 CACNA1G DMD RARB HDAC5 HDAC7 EFNB2 HEY1 NKX2-5 MYOCD ALPK2 PROX1 | 6.12e-05 | 558 | 210 | 17 | GO:0060537 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | MCIDAS FOXA1 MAGI2 NFE2L1 YAP1 NFIB GLI2 RPTOR MYO3B PLCB1 NKX2-2 DLX6 DMD POU2F3 RARB FLVCR2 TFAP2C HEY1 NKX2-5 RAPGEF2 PALLD PROX1 | 8.33e-05 | 870 | 210 | 22 | GO:0030855 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 8.66e-05 | 177 | 210 | 9 | GO:0055007 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | ADGRV1 FOXA1 HOXA2 YAP1 GLI2 NKX2-2 DMD LILRA2 RAP1GAP RARB HDAC5 APBB1 RUNX1T1 RUNX3 HDAC7 ARHGAP4 HEY1 NKX2-5 MYOCD RAPGEF2 PBX1 PROX1 | 9.06e-05 | 875 | 210 | 22 | GO:0045596 |
| GeneOntologyBiologicalProcess | epithelial cell development | FOXA1 MAGI2 YAP1 PLCB1 NKX2-2 DMD RARB TFAP2C RAPGEF2 PALLD PROX1 | 1.03e-04 | 269 | 210 | 11 | GO:0002064 |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway | 1.59e-04 | 113 | 210 | 7 | GO:2001237 | |
| GeneOntologyBiologicalProcess | epithelium development | TMPRSS13 MCIDAS FOXA1 MAGI2 PYGO2 NFE2L1 YAP1 NFIB GLI2 RPTOR MYO3B PLCB1 NKX2-2 DLX6 DMD POU2F3 KDM6A RARB HDAC5 KIF26B FLVCR2 RUNX3 TFAP2C EFNB2 HEY1 NKX2-5 RAPGEF2 PBX1 PALLD PROX1 | 2.05e-04 | 1469 | 210 | 30 | GO:0060429 |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 2.56e-04 | 122 | 210 | 7 | GO:0055013 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 2.69e-04 | 123 | 210 | 7 | GO:0045666 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 2.84e-04 | 164 | 210 | 8 | GO:0002065 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | ADGRB2 ADGRV1 FOXA1 HOXA2 JARID2 YAP1 NFIB GLI2 NKX2-2 DMD LILRA2 RAP1GAP RARB HDAC5 APBB1 RUNX1T1 RUNX3 HDAC7 ARHGAP4 HEY1 NKX2-5 MYOCD RAPGEF2 PBX1 ALPK2 PROX1 | 2.95e-04 | 1220 | 210 | 26 | GO:0051093 |
| GeneOntologyBiologicalProcess | ventricular cardiac myofibril assembly | 3.07e-04 | 3 | 210 | 2 | GO:0055005 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 3.37e-04 | 91 | 210 | 6 | GO:0002067 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 3.37e-04 | 91 | 210 | 6 | GO:0048663 | |
| GeneOntologyCellularComponent | chromatin | ANKRD31 RNF40 FOXA1 HOXA2 JARID2 NFE2L1 NFIB UBP1 PLCB1 ZBTB5 NKX2-2 DLX6 BRD1 POU2F3 TCF12 RARB HDAC5 POU2F2 REL SHLD1 RUNX3 SOX13 TFAP2C TFE3 PHC1 HEY1 BAZ2A SP9 NKX2-5 MYOCD ELK1 PBX1 ST18 AFF4 PROP1 PROX1 | 1.17e-06 | 1480 | 215 | 36 | GO:0000785 |
| GeneOntologyCellularComponent | somatodendritic compartment | ANKS1B DDN KCNB2 MAGI2 RPTOR AGFG1 CACNA1G DMD BRD1 KISS1 CACNA1B RAP1GAP MYOT SH3GL2 APBB1 CRTC1 AKAP12 EFNB2 TIAM1 FARP1 IGHMBP2 ELK1 MARK2 RAPGEF2 CAPRIN1 PALLD SAMD4A | 1.61e-04 | 1228 | 215 | 27 | GO:0036477 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | RIPK1 UBE4B SPEG MAML1 FOXA1 BIRC6 HOXA2 MAGI2 JARID2 PYGO2 TULP4 NFE2L1 NFIB GLI2 AMOTL1 SCN4A NKX2-2 DLX6 BRD1 MN1 KDM6A TCF12 DOK7 POU2F2 FLVCR2 RUNX3 PHC1 EFNB2 IGHMBP2 SP9 MYOCD PBX1 MBD5 CAPRIN1 PALLD PROX1 | 2.01e-06 | 1269 | 174 | 36 | MP:0011111 |
| MousePheno | sinoatrial block | 2.12e-06 | 18 | 174 | 5 | MP:0010520 | |
| MousePheno | prolonged P wave | 1.06e-05 | 12 | 174 | 4 | MP:0004071 | |
| MousePheno | abnormal sinoatrial node conduction | 1.23e-05 | 42 | 174 | 6 | MP:0006142 | |
| MousePheno | abnormal myocardial trabeculae morphology | 1.26e-05 | 144 | 174 | 10 | MP:0002189 | |
| MousePheno | decreased prepulse inhibition | MCIDAS DBNDD2 ADGRB2 ANKS1B ADGRV1 PRAG1 FMNL2 ZDHHC8 C2CD5 HOXA2 PLCB1 CRYBG1 RELL1 KLK15 TTC28 HIPK3 FAM53B ALPK2 | 1.95e-05 | 464 | 174 | 18 | MP:0009142 |
| MousePheno | abnormal prepulse inhibition | MCIDAS DBNDD2 ADGRB2 ANKS1B ADGRV1 PRAG1 FMNL2 ZDHHC8 C2CD5 HOXA2 PLCB1 CRYBG1 RELL1 KLK15 TTC28 HIPK3 DYRK1B FAM53B ALPK2 | 4.57e-05 | 542 | 174 | 19 | MP:0003088 |
| MousePheno | abnormal cranial foramen morphology | 5.05e-05 | 33 | 174 | 5 | MP:0030310 | |
| MousePheno | perinatal lethality | ZBTB20 RIPK1 TNRC6B BIRC6 HOXA2 MAGI2 JARID2 PYGO2 TULP4 NFE2L1 NFIB GLI2 AMOTL1 SCN4A DLX6 MN1 KDM6A KIF26B DOK7 POU2F2 FLVCR2 RUNX1T1 RUNX3 PHC1 EFNB2 NKX2-5 MBD5 CAPRIN1 AFF4 PROP1 | 5.82e-05 | 1130 | 174 | 30 | MP:0002081 |
| Domain | - | CNKSR1 MAGI2 MAST4 MAGI3 TIAM1 SNTG2 CARD11 FRMPD3 RAPGEF2 AHNAK2 | 8.44e-06 | 150 | 212 | 10 | 2.30.42.10 |
| Domain | PDZ | CNKSR1 MAGI2 MAST4 MAGI3 TIAM1 SNTG2 CARD11 FRMPD3 RAPGEF2 AHNAK2 | 8.95e-06 | 151 | 212 | 10 | PS50106 |
| Domain | PDZ | CNKSR1 MAGI2 MAST4 MAGI3 TIAM1 SNTG2 CARD11 FRMPD3 RAPGEF2 AHNAK2 | 9.49e-06 | 152 | 212 | 10 | IPR001478 |
| Domain | PH_dom-like | CNKSR1 ANKS1B AFAP1L2 PLCB1 TNS3 WASL RASGRF2 DOK7 APBB1 ARHGEF25 PLEKHG6 TIAM1 FARP1 SNTG2 FRMPD3 TNS1 | 3.05e-05 | 426 | 212 | 16 | IPR011993 |
| Domain | PDZ | 4.95e-05 | 148 | 212 | 9 | SM00228 | |
| Domain | SAM_1 | 1.21e-04 | 68 | 212 | 6 | PF00536 | |
| Domain | - | 1.28e-04 | 2 | 212 | 2 | 1.25.40.170 | |
| Domain | PHAT_dom | 1.28e-04 | 2 | 212 | 2 | IPR015327 | |
| Domain | WW | 1.87e-04 | 47 | 212 | 5 | PF00397 | |
| Domain | WW | 2.07e-04 | 48 | 212 | 5 | SM00456 | |
| Domain | PDZ | 2.10e-04 | 141 | 212 | 8 | PF00595 | |
| Domain | WW_DOMAIN_1 | 2.76e-04 | 51 | 212 | 5 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.76e-04 | 51 | 212 | 5 | PS50020 | |
| Domain | WW_dom | 3.03e-04 | 52 | 212 | 5 | IPR001202 | |
| Domain | TORC_N | 3.82e-04 | 3 | 212 | 2 | IPR024783 | |
| Domain | TORC | 3.82e-04 | 3 | 212 | 2 | IPR024786 | |
| Domain | TORC_M | 3.82e-04 | 3 | 212 | 2 | IPR024784 | |
| Domain | TORC_C | 3.82e-04 | 3 | 212 | 2 | IPR024785 | |
| Domain | TF_octamer | 3.82e-04 | 3 | 212 | 2 | IPR000972 | |
| Domain | TORC_N | 3.82e-04 | 3 | 212 | 2 | PF12884 | |
| Domain | TORC_M | 3.82e-04 | 3 | 212 | 2 | PF12885 | |
| Domain | TORC_C | 3.82e-04 | 3 | 212 | 2 | PF12886 | |
| Domain | - | CNKSR1 ANKS1B AFAP1L2 TNS3 WASL RASGRF2 DOK7 APBB1 ARHGEF25 PLEKHG6 TIAM1 FARP1 TNS1 | 5.51e-04 | 391 | 212 | 13 | 2.30.29.30 |
| Domain | DH_1 | 7.40e-04 | 63 | 212 | 5 | PS00741 | |
| Domain | Tensin_PTB | 7.58e-04 | 4 | 212 | 2 | IPR033929 | |
| Domain | Histone_deAcase_II_euk | 7.58e-04 | 4 | 212 | 2 | IPR017320 | |
| Domain | SAM | 8.35e-04 | 97 | 212 | 6 | IPR001660 | |
| Domain | RhoGEF | 1.05e-03 | 68 | 212 | 5 | SM00325 | |
| Domain | PTB | 1.07e-03 | 40 | 212 | 4 | SM00462 | |
| Domain | PTB/PI_dom | 1.18e-03 | 41 | 212 | 4 | IPR006020 | |
| Domain | RhoGEF | 1.20e-03 | 70 | 212 | 5 | PF00621 | |
| Domain | DH_2 | 1.20e-03 | 70 | 212 | 5 | PS50010 | |
| Domain | - | 1.27e-03 | 71 | 212 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.27e-03 | 71 | 212 | 5 | IPR000219 | |
| Domain | Homeobox_CS | 1.31e-03 | 186 | 212 | 8 | IPR017970 | |
| Domain | - | 1.32e-03 | 106 | 212 | 6 | 1.10.150.50 | |
| Domain | RasGEFN | 1.43e-03 | 20 | 212 | 3 | SM00229 | |
| Domain | Homeodomain-like | HOXA2 NKX2-2 DLX6 POU2F3 TCF12 POU2F2 NKX2-5 SNAPC4 PBX1 PROP1 PROX1 | 1.50e-03 | 332 | 212 | 11 | IPR009057 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP4 PRAG1 MAST4 YAP1 RPTOR AGFG1 NAV2 BRD1 TNS3 CRTC3 RAP1GAP SH3RF1 TTC28 KIF26B SAMD4B APBB1 MAGI3 CRTC1 ZNRF2 HDAC7 MICALL1 ARFGAP2 VPS13D MAP7D1 TIAM1 KIAA1217 ARFGAP1 DYRK1B FAM53B NUP93 MARK2 RAPGEF2 R3HDM1 PALLD SAMD4A AHNAK2 | 2.30e-19 | 861 | 219 | 36 | 36931259 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIC2 FOXA1 HOXA2 NFE2L1 NFIB UBP1 GLI2 NKX2-2 DLX6 POU2F3 IKZF3 TCF12 RARB KIAA1549 POU2F2 REL RUNX3 SOX13 TFAP2C TFE3 HEY1 SP9 NKX2-5 ELK1 SNAPC4 PBX1 ST18 PROP1 PROX1 | 8.65e-13 | 908 | 219 | 29 | 19274049 |
| Pubmed | MAML1 HIC2 RNF40 ADGRV1 MAST4 RPTOR PLCB1 NAV2 ZBTB5 RPRD2 CACNA1G FBF1 PHRF1 KIAA1549 CRTC1 MICALL1 ZFYVE28 ARHGAP4 GTF3C2 ZNF592 FAM53B NUP93 | 3.81e-12 | 529 | 219 | 22 | 14621295 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RIPK1 MAML1 YAP1 UBP1 RPTOR AGFG1 CRYBG1 RPRD2 DMD TNS3 CRTC3 RAP1GAP TCF12 HDAC5 SAMD4B CRTC1 REL ZNRF2 SOX13 TFE3 RABL6 ARFGAP2 SHROOM1 KIAA1217 ARFGAP1 CEP41 FAM53B RAPGEF2 R3HDM1 SAMD4A | 4.15e-12 | 1038 | 219 | 30 | 26673895 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZBTB20 FOXA1 HOXA2 NFIB UBP1 GLI2 DLX6 POU2F3 TCF12 RARB POU2F2 RUNX3 TFAP2C TFE3 HEY1 SP9 NKX2-5 ELK1 PBX1 PROP1 PROX1 | 4.79e-11 | 544 | 219 | 21 | 28473536 |
| Pubmed | TNRC6B KCNB2 ZDHHC8 LENG8 SH3RF1 TTC28 SYNM APBB1 KIAA1549 RABL6 KIAA1217 ARFGAP1 TMEM131 R3HDM1 AHNAK2 | 1.54e-10 | 263 | 219 | 15 | 34702444 | |
| Pubmed | CNKSR1 UBE4B TTLL5 ANKS1B RNF40 FMNL2 MAGI2 ZBTB5 KDM6A WASL RAP1GAP ZCCHC12 RARB WARS1 TTC28 SYNM APBB1 MAGI3 HEATR6 TIAM1 HEY1 ZNF592 RNF38 CIPC TMEM131 RAPGEF2 R3HDM1 PBX1 ST18 CAPRIN1 AFF4 | 1.63e-10 | 1285 | 219 | 31 | 35914814 | |
| Pubmed | RIPK1 FMNL2 LENG8 AGFG1 PLCB1 NAV2 DMD CRTC3 WASL SH3RF1 KIF26B CRTC1 MUC12 HIPK3 DYRK1B RAPGEF2 MBD5 MAP2K5 TNS1 | 3.37e-10 | 486 | 219 | 19 | 20936779 | |
| Pubmed | ZBTB20 FOXA1 BIRC6 NFE2L1 GLI2 DLX6 POU2F3 TCF12 RARB SH3RF1 POU2F2 TACC2 SOX13 TFAP2C TFE3 PHC1 RLF HEY1 BAZ2A IGHMBP2 PBX1 PROX1 | 9.99e-10 | 709 | 219 | 22 | 22988430 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZBTB20 MAML1 FOXA1 HOXA2 JARID2 NFE2L1 UBP1 ZBTB5 NKX2-2 BRD1 TCF12 RARB HDAC5 ZNF407 REL RUNX1T1 RUNX3 ZNF592 NKX2-5 MYOCD ELK1 SNAPC4 PBX1 PROX1 | 1.99e-09 | 877 | 219 | 24 | 20211142 |
| Pubmed | TNRC6B BIRC6 C2CD5 YAP1 AMOTL1 CRTC3 SH3RF1 HDAC5 TTC28 FBF1 SAMD4B KIAA1549 HDAC7 MARK2 RAPGEF2 R3HDM1 SAMD4A | 4.33e-09 | 446 | 219 | 17 | 24255178 | |
| Pubmed | MAML1 TNRC6B HIC2 FOXA1 LENG8 PYGO2 YAP1 NFIB GLI2 RPRD2 DLX6 KDM6A IKZF3 TCF12 HDAC5 REL SOX13 TFE3 RLF MAP7D1 GTF3C2 ZNF592 ARFGAP1 SP9 NKX2-5 NUP93 DOT1L R3HDM1 PBX1 CAPRIN1 | 8.21e-09 | 1429 | 219 | 30 | 35140242 | |
| Pubmed | ZBTB20 JARID2 NFE2L1 NFIB UBP1 ZBTB5 POU2F3 KDM6A TCF12 DUX4L9 POU2F2 RUNX3 SOX13 TFAP2C TFE3 PHC1 ARFGAP2 HEY1 ZNF592 BAZ2A ELK1 SNAPC4 | 1.07e-08 | 808 | 219 | 22 | 20412781 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZBTB20 UBE4B MAP4 TNRC6B ADGRV1 HM13 PTPRG TULP4 CD99 NFIB GLI2 RPTOR RPRD2 KDM6A SAMD4B RNF213 MAGI3 SLITRK3 RLF HIPK3 PARP10 EFNB2 FARP1 KIAA1217 SNTG2 RAPGEF2 PBX1 MBD5 ZMAT1 AFF4 | 2.06e-08 | 1489 | 219 | 30 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 UBE4B SPEG ADGRB2 MAML1 MED14 RNF40 PRAG1 BIRC6 ZDHHC8 TULP4 RPTOR NAV2 SH3RF1 HDAC7 TFE3 MICALL1 RABL6 ADAMTSL5 ZNF592 SORBS3 DOT1L SNAPC4 MBD5 AHNAK2 | 3.88e-08 | 1105 | 219 | 25 | 35748872 |
| Pubmed | TOGARAM1 FMNL2 BIRC6 C2CD5 PARP4 TULP4 RAP1GAP SH3RF1 ADAMTS4 SYNM RNF213 MAGI3 ZNF407 VPS13D MBD5 PALLD | 1.14e-07 | 493 | 219 | 16 | 15368895 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | CDHR5 FMNL2 ZDHHC8 AFAP1L2 PTPRG CD99 PLCB1 NAV2 RELL1 TNS3 WASL APBB1 KIAA1549 SLITRK3 MICALL1 FARP1 MARK2 | 1.48e-07 | 569 | 219 | 17 | 30639242 |
| Pubmed | CNKSR1 MAP4 ADAR PYGO2 YAP1 RPTOR NAV2 RPRD2 SAMD4B TACC2 GTF3C2 ARFGAP1 SORBS3 TMEM131 MARK2 PALLD | 1.50e-07 | 503 | 219 | 16 | 16964243 | |
| Pubmed | TNRC6B TOGARAM1 HIC2 ADGRV1 BIRC6 PLCB1 NAV2 RPRD2 CACNA1G HDAC5 TTC28 | 2.16e-07 | 225 | 219 | 11 | 12168954 | |
| Pubmed | ANKS1B ADGRV1 PMEPA1 MAGI2 PARP4 ATAD2B MYO3B NAV2 SAMD4B SH3GL2 MAGI3 TACC2 LINC02912 HDAC7 PLEKHG6 FARP1 RP1L1 RNFT1 FAM53B SAMD4A | 2.66e-07 | 814 | 219 | 20 | 23251661 | |
| Pubmed | MAP4 ADGRB2 ANKS1B TNRC6B HM13 KCNB2 BIRC6 MAGI2 RPTOR GLUD2 PLCB1 CACNA1B WARS1 OGFR SH3GL2 APBB1 TACC2 ARFGAP2 DZANK1 FARP1 KIAA1217 IGHMBP2 ARFGAP1 CAPRIN1 | 2.70e-07 | 1139 | 219 | 24 | 36417873 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TNRC6B PMEPA1 JARID2 PTPRG CD99 GLI2 BRD1 TCF12 ZNF407 TACC2 HIPK3 VPS13D TIAM1 KIAA1217 MARK2 MBD5 | 3.51e-07 | 536 | 219 | 16 | 15840001 |
| Pubmed | TNRC6B PMEPA1 JARID2 PTPRG CD99 GLI2 BRD1 TCF12 ZNF407 TACC2 HIPK3 VPS13D TIAM1 KIAA1217 MARK2 MBD5 | 3.69e-07 | 538 | 219 | 16 | 10512203 | |
| Pubmed | RIPK1 TNRC6B HM13 C2CD5 CD99 YAP1 AGFG1 WARS1 APBB1 AKAP12 MICALL1 ARFGAP2 EFNB2 HEY1 ARFGAP1 SORBS3 CEP41 TMEM131 MARK2 R3HDM1 CAPRIN1 PALLD | 4.81e-07 | 1007 | 219 | 22 | 34597346 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBE4B MAP4 MED14 C2CD5 FBXO38 YAP1 RPTOR MN1 KDM6A SAMD4B PHRF1 HDAC7 MICALL1 ZNF592 BAZ2A ARFGAP1 SORBS3 MARK2 SNAPC4 | 5.44e-07 | 774 | 219 | 19 | 15302935 |
| Pubmed | MAML1 TNRC6B FMNL2 BIRC6 CD99 AMOTL1 RELL1 TCF12 TTC28 SYNM APBB1 RNF213 AKAP12 RABL6 ARFGAP2 EFNB2 ARFGAP1 RAPGEF2 ZMAT1 | 5.77e-07 | 777 | 219 | 19 | 35844135 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ZDHHC8 C2CD5 AFAP1L2 PTPRG PLCB1 RELL1 DMD KIF26B AKAP12 MICALL1 TIAM1 FARP1 MARK2 | 9.28e-07 | 377 | 219 | 13 | 38117590 |
| Pubmed | MAML1 MED14 RNF40 FOXA1 LENG8 PYGO2 YAP1 NFIB RPRD2 KDM6A AFF4 | 1.22e-06 | 268 | 219 | 11 | 33640491 | |
| Pubmed | MAP4 MED14 TNRC6B ADAR YAP1 AMOTL1 RPRD2 KDM6A TTC28 APBB1 GTF3C2 BAZ2A ARFGAP1 DOT1L PALLD | 2.45e-06 | 549 | 219 | 15 | 38280479 | |
| Pubmed | TNRC6B HIC2 FOXA1 FMNL2 C2CD5 ZNF469 RPTOR ABHD8 BRD1 TCF12 TTC28 FBF1 PHRF1 KIAA1549 RNF213 ARHGAP4 MAP7D1 ZNF592 BAZ2A RAPGEF2 AFF4 PROX1 | 2.59e-06 | 1116 | 219 | 22 | 31753913 | |
| Pubmed | ADGRB2 ANKS1B ADGRV1 MAGI2 RPTOR AMOTL1 KIAA1549 RNF222 MAGI3 DZANK1 FARP1 MARK2 RAPGEF2 | 3.94e-06 | 430 | 219 | 13 | 32581705 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP4 TNRC6B ADAR PARP4 AGFG1 TNS3 WASL WARS1 AKAP12 MICALL1 MAP7D1 FARP1 TMEM131 R3HDM1 CAPRIN1 PALLD AHNAK2 | 3.97e-06 | 724 | 219 | 17 | 36232890 |
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 16980613 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTLL5 MAML1 TNRC6B LENG8 MAST4 WASL TTC28 SH3GL2 MAGI3 CRTC1 MICALL1 ARFGAP2 FARP1 KIAA1217 ARFGAP1 CEP41 TMEM131 NUP93 | 8.85e-06 | 853 | 219 | 18 | 28718761 |
| Pubmed | UBE4B SPEG DDN TNRC6B MAGI2 HDAC5 TTC28 MAP7D1 BAZ2A CIPC R3HDM1 ST18 | 1.19e-05 | 407 | 219 | 12 | 12693553 | |
| Pubmed | ADGRB2 ANKS1B DDN TNRC6B MAGI2 RPTOR PLCB1 SH3GL2 AKAP12 DZANK1 MAP7D1 FARP1 KIAA1217 FRMPD3 RAPGEF2 TNS1 CAPRIN1 AFF4 PROX1 | 1.27e-05 | 963 | 219 | 19 | 28671696 | |
| Pubmed | TNRC6B RNF40 BIRC6 HDAC5 TTC28 CRTC1 PHC1 RLF MAP7D1 GTF3C2 ZNF592 PROX1 | 1.56e-05 | 418 | 219 | 12 | 34709266 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAP4 FMNL2 CD99 YAP1 AGFG1 NAV2 CRYBG1 RELL1 SH3RF1 MAGI3 MICALL1 ARFGAP2 KIAA1217 MARK2 | 1.59e-05 | 565 | 219 | 14 | 25468996 |
| Pubmed | BIRC6 PARP4 NFE2L1 WASL TCF12 MYOT RASGRF2 ZNF407 AKAP12 MAP7D1 ZNF592 CIPC PALLD | 1.83e-05 | 497 | 219 | 13 | 23414517 | |
| Pubmed | 1.86e-05 | 233 | 219 | 9 | 37704626 | ||
| Pubmed | 1.96e-05 | 130 | 219 | 7 | 19386638 | ||
| Pubmed | 1.96e-05 | 130 | 219 | 7 | 12421765 | ||
| Pubmed | MAP4 C2CD5 MFAP3 NFE2L1 UBP1 EXOC3L4 CRYBG1 WARS1 CRTC1 TACC2 AKAP12 FARP1 ARFGAP1 RNF38 CIPC TMEM131 DOT1L TNS1 ZMAT1 AFF4 | 1.96e-05 | 1084 | 219 | 20 | 11544199 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MAP4 TOGARAM1 TNS3 FBF1 CRTC1 RLF MAP7D1 SHROOM1 ZNF592 CARD11 PALLD | 2.05e-05 | 361 | 219 | 11 | 26167880 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.35e-05 | 184 | 219 | 8 | 32908313 | |
| Pubmed | 2.38e-05 | 134 | 219 | 7 | 19030180 | ||
| Pubmed | XIRP1 SGK3 AFAP1L2 NFIB EXOC3L4 AMOTL1 RPRD2 SH3RF1 KIF26B SAMD4B AKAP12 PHC1 ARHGAP4 MBD5 SAMD4A | 3.55e-05 | 689 | 219 | 15 | 36543142 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 22584896 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 34480788 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 34156713 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 32450521 | ||
| Pubmed | Crescerin uses a TOG domain array to regulate microtubules in the primary cilium. | 3.95e-05 | 2 | 219 | 2 | 26378256 | |
| Pubmed | ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer. | 3.95e-05 | 2 | 219 | 2 | 34817735 | |
| Pubmed | AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. | 3.95e-05 | 2 | 219 | 2 | 32313226 | |
| Pubmed | Mammalian Smaug is a translational repressor that forms cytoplasmic foci similar to stress granules. | 3.95e-05 | 2 | 219 | 2 | 16221671 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27571517 | ||
| Pubmed | Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. | 3.95e-05 | 2 | 219 | 2 | 30046111 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 30061577 | ||
| Pubmed | Differential YAP nuclear signaling in healthy and dystrophic skeletal muscle. | 3.95e-05 | 2 | 219 | 2 | 30995108 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 20549724 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27926865 | ||
| Pubmed | Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle. | 3.95e-05 | 2 | 219 | 2 | 11316257 | |
| Pubmed | Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. | 3.95e-05 | 2 | 219 | 2 | 23737213 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 35954177 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 34381186 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 16803958 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 36716535 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19204326 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 27425596 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19289505 | ||
| Pubmed | Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. | 3.95e-05 | 2 | 219 | 2 | 23667252 | |
| Pubmed | Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. | 3.95e-05 | 2 | 219 | 2 | 27205883 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | RIPK1 TNRC6B AMOTL1 AGFG1 WASL WARS1 APBB1 ARFGAP2 ARFGAP1 PALLD | 4.16e-05 | 322 | 219 | 10 | 39098523 |
| Pubmed | 4.74e-05 | 102 | 219 | 6 | 9734811 | ||
| Pubmed | 5.81e-05 | 209 | 219 | 8 | 36779422 | ||
| Pubmed | 6.72e-05 | 13 | 219 | 3 | 23571217 | ||
| Pubmed | 6.72e-05 | 13 | 219 | 3 | 21093585 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | RNF40 HM13 NFIB AGFG1 NAV2 DMD WASL IKZF3 TCF12 MYOT RARB REL ARSA SORBS3 NKX2-5 | 8.14e-05 | 742 | 219 | 15 | 26871637 |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 8.27e-05 | 163 | 219 | 7 | 23333304 | |
| Pubmed | Endothelial Cyp26b1 restrains murine heart valve growth during development. | 8.27e-05 | 163 | 219 | 7 | 35364055 | |
| Pubmed | 8.52e-05 | 14 | 219 | 3 | 15601857 | ||
| Pubmed | 8.52e-05 | 14 | 219 | 3 | 22549777 | ||
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 8.52e-05 | 14 | 219 | 3 | 12015313 | |
| Pubmed | Histone deacetylase expression patterns in developing murine optic nerve. | 8.52e-05 | 14 | 219 | 3 | 25011550 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DDN ZNF469 TULP4 NFE2L1 YAP1 GLI2 AGFG1 CRTC3 HDAC5 RNF38 NKX2-5 | 9.87e-05 | 430 | 219 | 11 | 35044719 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MAML1 RNF40 YAP1 RPTOR AGFG1 IKZF3 SH3RF1 HDAC5 TTC28 TACC2 SOX13 KIAA1217 DOT1L | 1.01e-04 | 588 | 219 | 13 | 38580884 |
| Pubmed | 1.04e-04 | 169 | 219 | 7 | 31462741 | ||
| Pubmed | Identification of candidate genes at the corticoseptal boundary during development. | 1.06e-04 | 15 | 219 | 3 | 16458080 | |
| Pubmed | 1.06e-04 | 15 | 219 | 3 | 23782696 | ||
| Pubmed | Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice. | 1.07e-04 | 74 | 219 | 5 | 23604909 | |
| Pubmed | 1.17e-04 | 40 | 219 | 4 | 28805822 | ||
| Pubmed | Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. | 1.18e-04 | 3 | 219 | 2 | 21685940 | |
| Pubmed | Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway. | 1.18e-04 | 3 | 219 | 2 | 26986510 | |
| Pubmed | YAP promotes myogenic differentiation via the MEK5-ERK5 pathway. | 1.18e-04 | 3 | 219 | 2 | 28356344 | |
| Pubmed | Differential roles of ArfGAP1, ArfGAP2, and ArfGAP3 in COPI trafficking. | 1.18e-04 | 3 | 219 | 2 | 19015319 | |
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 22028467 | ||
| Pubmed | Regulation of cardiac growth and development by SRF and its cofactors. | 1.18e-04 | 3 | 219 | 2 | 12858529 | |
| Pubmed | Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia. | 1.18e-04 | 3 | 219 | 2 | 26677878 | |
| Pubmed | Three homologous ArfGAPs participate in coat protein I-mediated transport. | 1.18e-04 | 3 | 219 | 2 | 19299515 | |
| Pubmed | 1.18e-04 | 3 | 219 | 2 | 24327761 | ||
| Interaction | YWHAH interactions | SPEG PRAG1 MAST4 YAP1 RPTOR AGFG1 NAV2 BRD1 TNS3 CRTC3 RAP1GAP SH3RF1 HDAC5 TTC28 KIF26B SAMD4B APBB1 MAGI3 CRTC1 ZNRF2 HDAC7 TFE3 MICALL1 ARFGAP2 VPS13D MAP7D1 SHROOM1 TIAM1 KIAA1217 ARFGAP1 FAM53B MARK2 RAPGEF2 R3HDM1 PALLD SAMD4A AHNAK2 | 5.60e-10 | 1102 | 216 | 37 | int:YWHAH |
| Interaction | CREBBP interactions | MAML1 ANKS1B FBXO38 PYGO2 YAP1 NFIB KISS1 POU2F3 KDM6A ZCCHC12 TCF12 CRTC1 REL TACC2 HIPK3 TIAM1 ZNF592 DYRK1B ELK1 NUP93 MARK2 PBX1 PROX1 | 1.33e-07 | 599 | 216 | 23 | int:CREBBP |
| Interaction | YWHAG interactions | SPEG PRAG1 MAST4 YAP1 RPTOR AGFG1 NAV2 BRD1 TNS3 CRTC3 WASL RAP1GAP SH3RF1 HDAC5 TTC28 KIF26B SAMD4B APBB1 MAGI3 CRTC1 ZNRF2 HDAC7 TFE3 TGOLN2 MICALL1 VPS13D MAP7D1 SHROOM1 TIAM1 FAM53B MARK2 RAPGEF2 R3HDM1 SAMD4A AHNAK2 | 1.59e-07 | 1248 | 216 | 35 | int:YWHAG |
| Interaction | YWHAB interactions | SPEG FOXA1 MAST4 YAP1 NAV2 BRD1 TNS3 CRTC3 RAP1GAP SH3RF1 HDAC5 TTC28 KIF26B SAMD4B CRTC1 HDAC7 TFE3 TGOLN2 MICALL1 VPS13D MAP7D1 SHROOM1 TIAM1 FAM53B MARK2 DOT1L RAPGEF2 R3HDM1 SAMD4A AHNAK2 | 4.51e-07 | 1014 | 216 | 30 | int:YWHAB |
| Interaction | YWHAQ interactions | MAP4 SPEG PANK1 MAST4 YAP1 RPTOR AGFG1 NAV2 BRD1 TNS3 CRTC3 RAP1GAP SH3RF1 HDAC5 TTC28 KIF26B SAMD4B CRTC1 ZNRF2 HDAC7 TFE3 VPS13D MAP7D1 SHROOM1 TIAM1 FAM53B MARK2 RAPGEF2 R3HDM1 SAMD4A | 3.34e-06 | 1118 | 216 | 30 | int:YWHAQ |
| Interaction | SFN interactions | MAP4 MAST4 YAP1 NFIB NAV2 TNS3 CRTC3 RAP1GAP SH3RF1 HDAC5 KIF26B HDAC7 TFE3 MAP7D1 TIAM1 FAM53B NUP93 MARK2 MAP2K5 PALLD SAMD4A AHNAK2 | 5.67e-06 | 692 | 216 | 22 | int:SFN |
| Interaction | ZFPL1 interactions | KCNB2 FOXA1 CD99 AGFG1 RELL1 APBB1 KIAA1549 AKAP12 TGOLN2 MICALL1 ARFGAP2 VPS13D EFNB2 TIAM1 FARP1 MARK2 AHNAK2 | 7.26e-06 | 448 | 216 | 17 | int:ZFPL1 |
| Interaction | MCAM interactions | FMNL2 ZDHHC8 C2CD5 AFAP1L2 PTPRG PLCB1 RELL1 DMD KIF26B AKAP12 LGALS3 TGOLN2 MICALL1 SHROOM1 TIAM1 FARP1 MARK2 | 1.28e-05 | 468 | 216 | 17 | int:MCAM |
| Interaction | BAG2 interactions | VWA5B2 RIPK1 FOXA1 YAP1 RPTOR RPRD2 BRD1 KDM6A HDAC5 REL PHC1 ARFGAP2 VPS13D SHROOM1 GTF3C2 ELK1 DOT1L R3HDM1 MAP2K5 PALLD | 1.31e-05 | 622 | 216 | 20 | int:BAG2 |
| Interaction | CBY1 interactions | RPTOR CRTC3 HDAC5 CRTC1 HDAC7 MICALL1 TIAM1 FAM53B MARK2 PROP1 | 2.80e-05 | 182 | 216 | 10 | int:CBY1 |
| Interaction | YWHAZ interactions | SPEG MAST4 YAP1 RPTOR AMOTL1 NAV2 BRD1 CRTC3 RAP1GAP SH3RF1 HDAC5 TTC28 RASGRF2 KIF26B SAMD4B CRTC1 TACC2 HDAC7 TFE3 LGALS3 MICALL1 VPS13D MAP7D1 TIAM1 FAM53B MARK2 RAPGEF2 R3HDM1 MAP2K5 TNS1 SAMD4A | 3.12e-05 | 1319 | 216 | 31 | int:YWHAZ |
| Interaction | RND3 interactions | MAML1 KCNB2 C2CD5 PTPRG CD99 RELL1 KIAA1549 AKAP12 EFNB2 FARP1 KIAA1217 MARK2 | 4.10e-05 | 273 | 216 | 12 | int:RND3 |
| Interaction | SNTB1 interactions | 5.77e-05 | 63 | 216 | 6 | int:SNTB1 | |
| Interaction | RNF43 interactions | TNRC6B KCNB2 ZDHHC8 LENG8 SH3RF1 TTC28 SYNM APBB1 KIAA1549 RABL6 KIAA1217 ARFGAP1 TMEM131 R3HDM1 AHNAK2 | 6.12e-05 | 427 | 216 | 15 | int:RNF43 |
| Interaction | RXRB interactions | 7.52e-05 | 66 | 216 | 6 | int:RXRB | |
| Interaction | YWHAE interactions | PRAG1 MAST4 YAP1 RPTOR AMOTL1 NAV2 BRD1 CRTC3 RAP1GAP SH3RF1 HDAC5 TTC28 KIF26B SAMD4B CRTC1 TACC2 HDAC7 TFE3 TGOLN2 MICALL1 MAP7D1 TIAM1 FAM53B MARK2 DOT1L RAPGEF2 R3HDM1 CAPRIN1 SAMD4A | 7.90e-05 | 1256 | 216 | 29 | int:YWHAE |
| Interaction | RHOQ interactions | KCNB2 ZDHHC8 C2CD5 PTPRG RPTOR RELL1 TNS3 WASL KIAA1549 AKAP12 MICALL1 EFNB2 TIAM1 FARP1 MARK2 | 9.00e-05 | 442 | 216 | 15 | int:RHOQ |
| Interaction | PARD3 interactions | ZDHHC8 PTPRG YAP1 AMOTL1 PLCB1 KIAA1549 MAGI3 EFNB2 TIAM1 FARP1 KIAA1217 MARK2 | 9.48e-05 | 298 | 216 | 12 | int:PARD3 |
| Interaction | LYN interactions | KCNB2 FMNL2 ZDHHC8 C2CD5 PTPRG CD99 YAP1 PLCB1 RELL1 DMD SH3RF1 KIF26B AKAP12 MICALL1 EFNB2 TIAM1 FARP1 KIAA1217 MARK2 AHNAK2 | 1.01e-04 | 720 | 216 | 20 | int:LYN |
| Interaction | TBK1 interactions | RIPK1 TNRC6B ADAR YAP1 RPTOR AGFG1 BRD1 OGFR FBF1 SAMD4B CRTC1 REL LGALS3 KIAA1217 | 1.18e-04 | 402 | 216 | 14 | int:TBK1 |
| GeneFamily | PDZ domain containing | CNKSR1 MAGI2 MAST4 MAGI3 TIAM1 SNTG2 CARD11 FRMPD3 RAPGEF2 AHNAK2 | 4.37e-07 | 152 | 146 | 10 | 1220 |
| GeneFamily | Histone deacetylases, class IIA | 3.84e-04 | 4 | 146 | 2 | 992 | |
| GeneFamily | Sterile alpha motif domain containing | 7.33e-04 | 88 | 146 | 5 | 760 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.17e-03 | 26 | 146 | 3 | 904 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.76e-03 | 8 | 146 | 2 | 837 | |
| GeneFamily | Ring finger proteins | 1.79e-03 | 275 | 146 | 8 | 58 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.00e-03 | 66 | 146 | 4 | 722 | |
| GeneFamily | ArfGAPs | 2.36e-03 | 33 | 146 | 3 | 395 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.40e-03 | 11 | 146 | 2 | 1025 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | ZBTB20 FMNL2 MAST4 PTPRG NFIB TCF12 TTC28 RNF213 AKAP12 FARP1 KIAA1217 RAPGEF2 MBD5 ALPK2 SAMD4A | 2.54e-11 | 176 | 219 | 15 | M39223 |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | UBE4B MAML1 FBXO38 JARID2 PYGO2 SERINC4 CRYBG1 ZCCHC12 HDAC5 AKAP12 LGALS3 RAPGEF2 ZMAT1 | 1.51e-08 | 200 | 219 | 13 | M5069 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | UBE4B ANKS1B TNRC6B ADGRV1 LENG8 PTPRG NFE2L1 DMD KIF26B RGL3 KIAA1549 PARP10 BAZ2A MARK2 TNS1 ZMAT1 | 5.10e-07 | 417 | 219 | 16 | M39224 |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_UP | RNF40 ZBTB5 ALAS1 WASL OGFR REL RUNX3 EFNB2 TIAM1 NKX2-5 MARK2 PROX1 | 7.44e-07 | 235 | 219 | 12 | M6122 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | ZBTB20 PRAG1 MAGI2 AFAP1L2 PTPRG TULP4 CRTC3 SH3RF1 TACC2 AKAP12 HEY1 FARP1 KIAA1217 RNF38 FAM53B PBX1 TNS1 ZMAT1 | 7.97e-07 | 542 | 219 | 18 | M19529 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 2.22e-06 | 26 | 219 | 5 | M7999 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 2.22e-06 | 26 | 219 | 5 | MM510 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | ZBTB20 ANKS1B TNRC6B MAST4 PTPRG NFIB TTC28 FARP1 PBX1 MBD5 TNS1 | 2.78e-06 | 221 | 219 | 11 | M39222 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SPEG DDN FMNL2 SGK3 MAGI2 JARID2 PARP4 AFAP1L2 MAST4 PTPRG AMOTL1 AGFG1 KDM6A ZNRF2 HIPK3 EFNB2 RNFT1 RAPGEF2 MBD5 PALLD SAMD4A | 1.09e-05 | 854 | 219 | 21 | M1533 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | TMEM74B SPEG HIC2 CACNA1G CACNA1B RAP1GAP RNF213 POU2F2 R3HDM1 | 1.15e-05 | 166 | 219 | 9 | M39026 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ZBTB20 TNRC6B PRAG1 MAGI2 PTPRG TULP4 RELL1 DMD TNS3 CRTC3 RAP1GAP SH3RF1 RNF213 HIPK3 ARFGAP2 KIAA1217 RNF38 TNS1 AFF4 PROX1 | 1.60e-05 | 807 | 219 | 20 | M16651 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SPEG DDN FMNL2 SGK3 MAGI2 JARID2 PARP4 AFAP1L2 MAST4 PTPRG AMOTL1 AGFG1 KDM6A ZNRF2 HIPK3 EFNB2 RNFT1 RAPGEF2 MBD5 PALLD SAMD4A | 1.95e-05 | 888 | 219 | 21 | MM1018 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP | 2.09e-05 | 179 | 219 | 9 | M8828 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 3.63e-05 | 192 | 219 | 9 | M8272 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 3.78e-05 | 193 | 219 | 9 | M3303 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 3.94e-05 | 242 | 219 | 10 | M12816 | |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 4.62e-05 | 198 | 219 | 9 | M4247 | |
| Coexpression | GUO_HEX_TARGETS_UP | 4.94e-05 | 78 | 219 | 6 | M1436 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 5.02e-05 | 155 | 219 | 8 | M39246 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZBTB20 SPEG DBNDD2 TTLL5 TNRC6B PRAG1 FMNL2 TMEM71 TULP4 NAV2 KDM6A TCF12 HDAC5 ADAMTS4 KIAA1549 ARHGEF25 SOX13 HEY1 SORBS3 FAM53B KCTD18 TNS1 ZMAT1 | 5.44e-05 | 1102 | 219 | 23 | M2369 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.50e-05 | 157 | 219 | 8 | M7733 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN | 6.07e-05 | 50 | 219 | 5 | M5077 | |
| Coexpression | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP | 7.16e-05 | 27 | 219 | 4 | M14614 | |
| Coexpression | PEREZ_TP53_TARGETS | CNKSR1 ZBTB20 MAML1 HIC2 ADGRV1 F8 AMOTL1 ZBTB5 BRD1 MN1 KDM6A HDAC5 SYNM KIF26B PHRF1 KIAA1549 RNF213 HIPK3 ZFYVE28 KIAA1217 FAM53B CIPC TNS1 AHNAK2 | 7.32e-05 | 1201 | 219 | 24 | M4391 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZBTB20 SPEG DBNDD2 TTLL5 TNRC6B PRAG1 FMNL2 TMEM71 TULP4 NAV2 KDM6A TCF12 HDAC5 ADAMTS4 KIAA1549 ARHGEF25 SOX13 HEY1 SORBS3 FAM53B KCTD18 TNS1 ZMAT1 | 7.33e-05 | 1124 | 219 | 23 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 8.56e-05 | 86 | 219 | 6 | M39247 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 9.22e-05 | 169 | 219 | 8 | M39230 | |
| Coexpression | LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED | 1.10e-04 | 30 | 219 | 4 | M39220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZBTB20 TOGARAM1 C2CD5 JARID2 YAP1 NFIB ATAD2B AGFG1 DMD MN1 TCF12 TTC28 RLF GTF3C2 TIAM1 TMEM131 RAPGEF2 R3HDM1 SAMD4A | 1.13e-04 | 856 | 219 | 19 | M4500 |
| Coexpression | HEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_PROJECTION_NEURONS | 1.14e-04 | 57 | 219 | 5 | MM415 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | ATAD2B CACNA1B ZCCHC12 POU2F2 RUNX1T1 RABL6 ARSA BAZ2A IGHMBP2 TMEM131 DOT1L SNAPC4 | 1.15e-04 | 389 | 219 | 12 | M39102 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 1.22e-04 | 176 | 219 | 8 | M7725 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.43e-04 | 180 | 219 | 8 | M6878 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ZBTB20 TNRC6B NFIB ATAD2B CRYBG1 DMD RNF38 PBX1 CAPRIN1 PALLD | 1.71e-04 | 289 | 219 | 10 | M2196 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 1.99e-04 | 189 | 219 | 8 | M8275 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN | 2.46e-04 | 195 | 219 | 8 | M3252 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HBZ | 2.52e-04 | 37 | 219 | 4 | MM509 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HBZ | 2.52e-04 | 37 | 219 | 4 | M802 | |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_DN | 2.64e-04 | 197 | 219 | 8 | M4509 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | MCIDAS ADGRB2 ADGRV1 AFAP1L2 NFIB GLI2 NKX2-2 HS3ST2 TNS3 RASGRF2 KIF26B FLVCR2 SOX13 LGALS3 SHROOM1 ADAMTSL5 KIAA1217 SP9 SNTG2 MYOCD PROX1 | 2.82e-04 | 1074 | 219 | 21 | M1941 |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 2.83e-04 | 199 | 219 | 8 | M5368 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP | 2.85e-04 | 107 | 219 | 6 | M7141 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 2.92e-04 | 200 | 219 | 8 | M9459 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.92e-04 | 200 | 219 | 8 | M291 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP | 2.92e-04 | 200 | 219 | 8 | M3312 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.92e-04 | 200 | 219 | 8 | M302 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_DN | 2.92e-04 | 200 | 219 | 8 | M4818 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 2.92e-04 | 200 | 219 | 8 | M9925 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 2.92e-04 | 200 | 219 | 8 | M8506 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP | 2.92e-04 | 200 | 219 | 8 | M6369 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN | 2.92e-04 | 200 | 219 | 8 | M6414 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN | 2.92e-04 | 200 | 219 | 8 | M6408 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 2.92e-04 | 200 | 219 | 8 | M7961 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 2.92e-04 | 200 | 219 | 8 | M7850 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_UP | 2.92e-04 | 200 | 219 | 8 | M5747 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 3.21e-04 | 256 | 219 | 9 | M828 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL | 3.24e-04 | 71 | 219 | 5 | M45677 | |
| Coexpression | BIDUS_METASTASIS_DN | 3.25e-04 | 154 | 219 | 7 | M8818 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ZBTB20 DBNDD2 FOXA1 PMEPA1 HOXA2 MAGI2 NFIB CRYBG1 ABHD8 DMD TTC28 PHC1 ARHGAP4 EFNB2 PBX1 AFF4 | 3.97e-04 | 721 | 219 | 16 | M1999 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ZBTB20 MAP4 HM13 BIRC6 PMEPA1 MAST4 TULP4 NFIB NAV2 KDM6A SH3RF1 RUNX1T1 RLF VPS13D KIAA1217 ARFGAP1 MYOCD ELK1 R3HDM1 KCTD18 TNS1 SAMD4A AHNAK2 | 4.20e-06 | 790 | 211 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | ZBTB20 TMPRSS13 MAP4 DBNDD2 MED14 FOXA1 TMEM71 CRYBG1 RPRD2 CACNA1B MYOT SYNM SH3GL2 FLVCR2 TFAP2C LGALS3 HIPK3 SNTG2 MYOCD TNS1 SAMD4A AHNAK2 | 9.62e-06 | 772 | 211 | 22 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | ZBTB20 MAP4 HM13 PMEPA1 MAST4 NFIB NAV2 KDM6A SH3RF1 RUNX1T1 RLF KIAA1217 MYOCD R3HDM1 TNS1 | 1.44e-05 | 406 | 211 | 15 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TMPRSS13 SPEG FOXA1 BIRC6 PTPRG GLI2 MN1 CACNA1B WASL RARB TTC28 KIF26B RUNX1T1 TFAP2C HIPK3 HEATR6 EFNB2 TIAM1 RNF38 SNTG2 MYOCD CAPRIN1 | 1.87e-05 | 806 | 211 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MAP4 MED14 TNRC6B HM13 FOXA1 BIRC6 PTPRG TULP4 RPTOR CACNA1B WASL RARB TTC28 KIF26B RUNX1T1 TFAP2C HIPK3 HEATR6 EFNB2 RNF38 MYOCD CAPRIN1 | 2.34e-05 | 818 | 211 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MED14 TNRC6B HM13 BIRC6 TULP4 RPTOR WASL RARB TTC28 HIPK3 HEATR6 RNF38 MYOCD CAPRIN1 | 3.33e-05 | 385 | 211 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | PRAG1 ZDHHC8 PMEPA1 AGFG1 ABHD8 IKZF3 TTC28 RNF213 TACC2 RUNX3 SOX13 LGALS3 FARP1 MARK2 | 4.52e-05 | 396 | 211 | 14 | GSM605799_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | ZBTB20 TMPRSS13 MAP4 DBNDD2 FOXA1 TMEM71 CRYBG1 DMD IKZF3 RASGRF2 SYNM SH3GL2 TFAP2C LGALS3 HIPK3 SNTG2 MYOCD TNS1 SAMD4A AHNAK2 | 4.67e-05 | 734 | 211 | 20 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | TMPRSS13 FOXA1 CACNA1B RARB TTC28 KIF26B RUNX1T1 TFAP2C HIPK3 TIAM1 RNF38 SNTG2 MYOCD CAPRIN1 | 6.06e-05 | 407 | 211 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.31e-04 | 150 | 211 | 8 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | MAP4 HM13 MAST4 NFIB NAV2 RUNX1T1 KIAA1217 ARFGAP1 ELK1 R3HDM1 KCTD18 | 1.35e-04 | 284 | 211 | 11 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | TMPRSS13 MAP4 DBNDD2 FOXA1 CRYBG1 SYNM TFAP2C LGALS3 HIPK3 SNTG2 MYOCD TNS1 SAMD4A | 1.44e-04 | 388 | 211 | 13 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | ZBTB20 MAP4 HM13 BIRC6 PMEPA1 MAST4 NFIB AMOTL1 NAV2 KDM6A SH3RF1 RUNX1T1 RLF KIAA1217 ARFGAP1 MYOCD R3HDM1 TNS1 SAMD4A AHNAK2 | 1.48e-04 | 799 | 211 | 20 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FOXA1 BIRC6 ZNF469 TULP4 NFIB RPTOR PLCB1 RELL1 RARB ADAMTS4 RUNX1T1 TFAP2C MICALL1 RLF HIPK3 HEATR6 SNTG2 MYOCD CAPRIN1 AHNAK2 | 1.80e-04 | 811 | 211 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FMNL2 PANK1 MAGI2 PTPRG NFIB GLI2 CACNA1G TNS3 RARB KIF26B RNF213 RUNX1T1 HEY1 FARP1 KIAA1217 ARFGAP1 SORBS3 CEP41 ZMAT1 PALLD | 2.32e-04 | 827 | 211 | 20 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | NFIB PLCB1 CACNA1G ALAS1 TNS3 CRTC3 RAP1GAP RARB TTC28 KIF26B KIAA1549 RNF213 CRTC1 SHLD1 RUNX1T1 ADAMTSL5 ZMAT1 | 2.46e-04 | 642 | 211 | 17 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | ZBTB20 SPEG MED14 FOXA1 NFIB PLCB1 RELL1 WASL ZCCHC12 TCF12 RARB SH3GL2 KIAA1549 AKAP12 MICALL1 SNTG2 MYOCD R3HDM1 KCTD18 | 2.69e-04 | 772 | 211 | 19 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | MAP4 TNRC6B FOXA1 BIRC6 RPTOR CACNA1B RARB TTC28 KIF26B RUNX1T1 HIPK3 HEATR6 EFNB2 | 2.84e-04 | 416 | 211 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.96e-04 | 91 | 211 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 2.99e-04 | 59 | 211 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MAP4 TTLL5 TNRC6B PANK1 C2CD5 MFAP3 MAST4 GLI2 ATAD2B KDM6A TTC28 MAP7D1 HEATR6 RNF38 ELK1 SNAPC4 R3HDM1 MBD5 AFF4 | 3.05e-04 | 780 | 211 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | PMEPA1 NFIB ATAD2B PLCB1 CACNA1G ALAS1 TNS3 CRTC3 RAP1GAP TTC28 KIF26B KIAA1549 RNF213 RUNX1T1 ADAMTSL5 ZMAT1 | 3.22e-04 | 596 | 211 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | MED14 FMNL2 PANK1 MAGI2 PTPRG NFIB GLI2 NAV2 ALAS1 KDM6A TNS3 RARB KIF26B RNF213 REL RUNX1T1 HEY1 KIAA1217 SORBS3 PALLD | 3.73e-04 | 858 | 211 | 20 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | PMEPA1 NFIB PLCB1 CACNA1G ALAS1 TNS3 CRTC3 RAP1GAP TTC28 KIF26B KIAA1549 RNF213 CRTC1 SHLD1 RUNX1T1 VPS13D ADAMTSL5 ZMAT1 | 3.88e-04 | 731 | 211 | 18 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | PMEPA1 NFIB PLCB1 CACNA1G ALAS1 TNS3 CRTC3 RAP1GAP TTC28 KIF26B KIAA1549 RNF213 CRTC1 SHLD1 RUNX1T1 VPS13D ADAMTSL5 ZMAT1 | 4.07e-04 | 734 | 211 | 18 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | MAP4 ADGRB2 ANKS1B PTPRG NFIB GLI2 PRRG3 CACNA1G DMD MN1 CRTC3 TCF12 HDAC5 KIF26B KIAA1549 SHLD1 RUNX1T1 ARHGEF25 HDAC7 SORBS3 MARK2 SNAPC4 MAP2K5 PALLD SAMD4A | 4.19e-04 | 1208 | 211 | 25 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | ZBTB20 TMPRSS13 FOXA1 TMEM71 SYNM SH3GL2 LGALS3 HIPK3 SNTG2 TNS1 SAMD4A AHNAK2 | 4.22e-04 | 378 | 211 | 12 | gudmap_developingLowerUrinaryTract_adult_bladder_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ZBTB20 MAP4 HM13 BIRC6 PMEPA1 MAST4 TULP4 NFIB AMOTL1 NAV2 KDM6A SH3RF1 RUNX1T1 RLF KIAA1217 ARFGAP1 ELK1 R3HDM1 TNS1 | 4.24e-04 | 801 | 211 | 19 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | ZDHHC8 TMEM71 PMEPA1 AGFG1 ABHD8 CRTC3 IKZF3 TTC28 RNF213 RUNX3 HDAC7 MARK2 | 4.64e-04 | 382 | 211 | 12 | GSM476684_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 4.70e-04 | 65 | 211 | 5 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_500 | 5.05e-04 | 66 | 211 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k3 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | PRAG1 ZDHHC8 TMEM71 PMEPA1 ABHD8 CRTC3 IKZF3 TTC28 RUNX3 HDAC7 FAM53B MARK2 | 5.32e-04 | 388 | 211 | 12 | GSM605790_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP4 FOXA1 BIRC6 PTPRG PLCB1 RPRD2 CACNA1B RARB KIF26B RUNX1T1 TFAP2C RLF HIPK3 DZANK1 EFNB2 RNF38 MYOCD ST18 CAPRIN1 | 5.47e-04 | 818 | 211 | 19 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 ADGRV1 MAGI2 PTPRG YAP1 NAV2 DMD KDM6A TCF12 SH3RF1 TTC28 MAGI3 ZNF407 RAPGEF2 MBD5 | 7.18e-14 | 198 | 219 | 15 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 ANKS1B ADGRV1 MAGI2 PTPRG YAP1 NAV2 DMD TCF12 TTC28 MAGI3 ZNF407 RAPGEF2 MBD5 | 1.11e-12 | 196 | 219 | 14 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 TNRC6B FMNL2 BIRC6 MAGI2 DMD KDM6A TCF12 TTC28 MAGI3 ZNF407 RAPGEF2 MBD5 | 2.24e-11 | 199 | 219 | 13 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | F8 MAST4 PTPRG PLCB1 RASGRF2 RUNX1T1 SOX13 EFNB2 HEY1 KIAA1217 SNTG2 RAPGEF2 | 9.93e-11 | 179 | 219 | 12 | 2a53d94f6c30bf887dfe88f1693ea057218c852d |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | F8 MAST4 PTPRG PLCB1 RASGRF2 SOX13 ARHGAP4 SHROOM1 EFNB2 HEY1 SNTG2 RAPGEF2 | 1.65e-10 | 187 | 219 | 12 | 40ffc06a3e3251d9b12da390210d3e045af7537a |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | ZBTB20 TNRC6B BIRC6 PLCB1 KDM6A IKZF3 RNF213 ZNF407 REL RLF TMEM131 RAPGEF2 | 1.75e-10 | 188 | 219 | 12 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SPEG FMNL2 GLI2 AMOTL1 NAV2 KIF26B TACC2 AKAP12 MYOCD TNS1 SAMD4A | 2.17e-09 | 185 | 219 | 11 | e58a009aaf342be019a909747b1895d5987d4daf |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | ZBTB20 NEK10 YAP1 PLCB1 DMD TNS3 RASGRF2 FLVCR2 FARP1 MBD5 SAMD4A | 2.42e-09 | 187 | 219 | 11 | f3e37c18ac6471c7992609bbddfa4975571c815c |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | SPEG MAGI2 PTPRG YAP1 DMD TTC28 KIF26B AKAP12 MYOCD PBX1 PALLD | 2.42e-09 | 187 | 219 | 11 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | F8 PTPRG NFIB SERINC4 PLCB1 WARS1 TTC28 RUNX1T1 EFNB2 HEY1 KIAA1217 | 2.56e-09 | 188 | 219 | 11 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | ZBTB20 TNRC6B MAGI2 MAST4 PTPRG TCF12 SH3RF1 TTC28 FARP1 RAPGEF2 MBD5 | 3.20e-09 | 192 | 219 | 11 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ANKS1B PRAG1 MAGI2 PTPRG GLI2 RARB TTC28 RUNX1T1 TIAM1 FARP1 MBD5 | 3.76e-09 | 195 | 219 | 11 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | PRAG1 F8 PLCB1 WARS1 RASGRF2 KIAA1549 RUNX1T1 EFNB2 HEY1 KIAA1217 SNTG2 | 3.76e-09 | 195 | 219 | 11 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | TNRC6B FMNL2 PMEPA1 PYGO2 NFE2L1 SAMD4B MAGI3 FRMPD3 MBD5 ALPK2 | 1.73e-08 | 175 | 219 | 10 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | ADGRV1 MAST4 YAP1 NFIB NAV2 SH3RF1 MAGI3 TACC2 TFAP2C KIAA1217 | 3.08e-08 | 186 | 219 | 10 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.24e-08 | 187 | 219 | 10 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.41e-08 | 188 | 219 | 10 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | PRAG1 F8 PTPRG NFIB PLCB1 RASGRF2 EFNB2 KIAA1217 SNTG2 RAPGEF2 | 3.58e-08 | 189 | 219 | 10 | fe49852ba15f948b384d6b4c258927c70b741357 |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | ADGRV1 MAST4 YAP1 NFIB NAV2 SH3RF1 MAGI3 TACC2 TFAP2C KIAA1217 | 3.96e-08 | 191 | 219 | 10 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | TNRC6B PRAG1 JARID2 PLCB1 KDM6A TTC28 MAGI3 FLVCR2 MBD5 AFF4 | 4.16e-08 | 192 | 219 | 10 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | TNRC6B PRAG1 JARID2 PLCB1 KDM6A TTC28 MAGI3 FLVCR2 MBD5 AFF4 | 4.37e-08 | 193 | 219 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | F8 PTPRG NFIB TTC28 KIAA1549 RUNX1T1 SOX13 EFNB2 HEY1 KIAA1217 | 4.58e-08 | 194 | 219 | 10 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.81e-08 | 195 | 219 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.05e-08 | 196 | 219 | 10 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.30e-08 | 197 | 219 | 10 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MAGI2 MAST4 PTPRG YAP1 RASGRF2 RUNX1T1 SOX13 SHROOM1 HEY1 TNS1 | 6.10e-08 | 200 | 219 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-07 | 168 | 219 | 9 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-07 | 173 | 219 | 9 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.10e-07 | 182 | 219 | 9 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 183 | 219 | 9 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.40e-07 | 184 | 219 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.40e-07 | 184 | 219 | 9 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-07 | 185 | 219 | 9 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-07 | 185 | 219 | 9 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-07 | 186 | 219 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-07 | 186 | 219 | 9 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.73e-07 | 186 | 219 | 9 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.26e-07 | 189 | 219 | 9 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-07 | 189 | 219 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.26e-07 | 189 | 219 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 4.46e-07 | 190 | 219 | 9 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.46e-07 | 190 | 219 | 9 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-07 | 191 | 219 | 9 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-07 | 191 | 219 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | (5)_Epi_basal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.66e-07 | 191 | 219 | 9 | 6bda3d5a8a391d41bb4d65872492e6c094bcc4d4 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.87e-07 | 192 | 219 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-07 | 192 | 219 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 4.87e-07 | 192 | 219 | 9 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.87e-07 | 192 | 219 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-07 | 192 | 219 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.08e-07 | 193 | 219 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.08e-07 | 193 | 219 | 9 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 195 | 219 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.54e-07 | 195 | 219 | 9 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 6.04e-07 | 197 | 219 | 9 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.04e-07 | 197 | 219 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.04e-07 | 197 | 219 | 9 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.04e-07 | 197 | 219 | 9 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.23e-07 | 145 | 219 | 8 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.30e-07 | 198 | 219 | 9 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.57e-07 | 199 | 219 | 9 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.57e-07 | 199 | 219 | 9 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.36e-07 | 153 | 219 | 8 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-06 | 163 | 219 | 8 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-06 | 164 | 219 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.65e-06 | 165 | 219 | 8 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.07e-06 | 170 | 219 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 171 | 219 | 8 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-06 | 173 | 219 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 179 | 219 | 8 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.03e-06 | 179 | 219 | 8 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 3.03e-06 | 179 | 219 | 8 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.29e-06 | 181 | 219 | 8 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 182 | 219 | 8 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 182 | 219 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-06 | 183 | 219 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.57e-06 | 183 | 219 | 8 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-06 | 183 | 219 | 8 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.03e-06 | 186 | 219 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-06 | 186 | 219 | 8 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 186 | 219 | 8 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 4.03e-06 | 186 | 219 | 8 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 187 | 219 | 8 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 187 | 219 | 8 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 187 | 219 | 8 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.19e-06 | 187 | 219 | 8 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 187 | 219 | 8 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 188 | 219 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 188 | 219 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 188 | 219 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.36e-06 | 188 | 219 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 188 | 219 | 8 | ed074572e61d97c139fb1636a78c9b71e2c44ce0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 188 | 219 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A | TTLL5 DDN ABHD8 OGFR REL RUNX3 HDAC7 RABL6 MAP7D1 RNFT1 FAM53B ELK1 TNS1 | 6.86e-08 | 199 | 218 | 13 | 6355_DN |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | TTLL5 ADGRB2 MED14 PLCB1 NAV2 POU2F2 MICALL1 VPS13D BAZ2A SORBS3 ELK1 AHNAK2 | 4.22e-07 | 195 | 218 | 12 | 5330_UP |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; PC3; HT_HG-U133A | UBE4B MAP4 SPEG TTLL5 OGFR SOX13 MICALL1 VPS13D HEATR6 PLEKHG6 BAZ2A SNAPC4 | 4.97e-07 | 198 | 218 | 12 | 2100_DN |
| Drug | Sp 1 (pharmaceutical) | MAML1 MED14 FOXA1 PMEPA1 NFE2L1 UBP1 KISS1 LILRA2 HDAC5 RGL3 POU2F2 REL RUNX1T1 TFAP2C TFE3 KCNH4 SORBS3 NKX2-5 MARK2 | 1.52e-06 | 548 | 218 | 19 | CID000099040 |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | UBE4B SLC2A8 SYNM SOX13 TFAP2C VPS13D BAZ2A FARP1 SORBS3 ELK1 SNAPC4 | 2.73e-06 | 193 | 218 | 11 | 1233_DN |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | TMEM74B TTLL5 ADGRB2 DDN OGFR HDAC7 VPS13D PLEKHG6 TIAM1 BAZ2A TNS1 | 3.17e-06 | 196 | 218 | 11 | 3724_DN |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | ZBTB20 ABHD8 HDAC5 SH3GL2 VPS13D TIAM1 ZNF592 SORBS3 FAM53B PBX1 MAP2K5 | 3.32e-06 | 197 | 218 | 11 | 5780_DN |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | HOXA2 MFAP3 NFIB ZNF407 RUNX1T1 HDAC7 TFAP2C RNFT1 R3HDM1 PBX1 TNS1 | 3.32e-06 | 197 | 218 | 11 | 7262_UP |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | UBE4B MAML1 MFAP3 PLCB1 KDM6A OGFR HIPK3 VPS13D SORBS3 MAP2K5 AFF4 | 3.32e-06 | 197 | 218 | 11 | 2768_DN |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | DDN C10orf95 HIC2 ATAD2B PLCB1 DLX6 CRTC1 BAZ2A RNFT1 TNS1 AHNAK2 | 3.49e-06 | 198 | 218 | 11 | 4842_UP |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | MAP4 NFIB AGFG1 POU2F3 POU2F2 RUNX1T1 CEP41 MARK2 PBX1 FUT6 TNS1 | 3.66e-06 | 199 | 218 | 11 | 4334_UP |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | ZBTB20 SPEG HIC2 HDAC7 SOX13 TFAP2C VPS13D SNAPC4 R3HDM1 FUT6 | 1.64e-05 | 191 | 218 | 10 | 4094_DN |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | SPEG TTLL5 FBXO38 PLCB1 KDM6A HDAC7 MICALL1 HIPK3 VPS13D MARK2 | 1.71e-05 | 192 | 218 | 10 | 3400_DN |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.71e-05 | 192 | 218 | 10 | 6728_UP | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.87e-05 | 194 | 218 | 10 | 4092_UP | |
| Drug | Fonofos | FOXA1 HOXA2 PTPRG YAP1 GLUD2 CRYBG1 HS3ST2 MN1 KLK15 RAP1GAP HDAC5 SH3GL2 LAIR1 SLITRK3 RUNX3 TFAP2C TFE3 FARP1 DYRK1B MYOCD | 1.91e-05 | 714 | 218 | 20 | ctd:D004397 |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | SPEG FBXO38 NFIB OGFR TFAP2C ZNF592 ELK1 MAP2K5 CAPRIN1 AFF4 | 1.96e-05 | 195 | 218 | 10 | 3714_DN |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | MAP4 MAST4 PLCB1 BRD1 OGFR AKAP12 DZANK1 FARP1 SORBS3 MAP2K5 | 1.96e-05 | 195 | 218 | 10 | 7033_UP |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | ADGRB2 HIC2 PMEPA1 JARID2 NFIB SH3GL2 RUNX3 BAZ2A FAM53B R3HDM1 | 1.96e-05 | 195 | 218 | 10 | 7504_UP |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 4587_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | CNKSR1 UBE4B MAP4 TTLL5 MAST4 KDM6A VPS13D BAZ2A RNFT1 MAP2K5 | 2.05e-05 | 196 | 218 | 10 | 1685_DN |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A | TNRC6B WASL MICALL1 RABL6 VPS13D HEATR6 HEY1 NUP93 CAPRIN1 PALLD | 2.05e-05 | 196 | 218 | 10 | 1961_UP |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | MAP4 NFIB PLCB1 KDM6A OGFR CRTC1 AKAP12 FARP1 SORBS3 RAPGEF2 | 2.14e-05 | 197 | 218 | 10 | 6012_DN |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A | TTLL5 DDN HIC2 MAGI2 RUNX1T1 RUNX3 HDAC7 IGHMBP2 FAM53B SNAPC4 | 2.14e-05 | 197 | 218 | 10 | 5106_UP |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.14e-05 | 197 | 218 | 10 | 5537_UP | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A | CNKSR1 MED14 ABHD8 FLVCR2 HDAC7 TFAP2C VPS13D RNFT1 SNAPC4 PBX1 | 2.14e-05 | 197 | 218 | 10 | 5801_DN |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.14e-05 | 197 | 218 | 10 | 5805_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | CNKSR1 UBE4B MAP4 TTLL5 REL VPS13D MAP7D1 FARP1 MARK2 RAPGEF2 | 2.14e-05 | 197 | 218 | 10 | 6360_DN |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | RAP1GAP SLC2A8 OGFR CRTC1 RUNX3 HIPK3 VPS13D FAM53B SNAPC4 SAMD4A | 2.23e-05 | 198 | 218 | 10 | 5064_DN |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 4353_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.33e-05 | 199 | 218 | 10 | 900_DN | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | MED14 DDN RNF40 MAST4 RAP1GAP ZNF407 RUNX1T1 ARFGAP1 SNAPC4 FUT6 | 2.33e-05 | 199 | 218 | 10 | 7125_UP |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 2.33e-05 | 199 | 218 | 10 | 3265_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | UBE4B SPEG TNRC6B RNF40 KDM6A TTC28 FARP1 SORBS3 MAP2K5 TNS1 | 2.33e-05 | 199 | 218 | 10 | 7254_DN |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.33e-05 | 199 | 218 | 10 | 6361_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.33e-05 | 199 | 218 | 10 | 3780_DN | |
| Drug | terbufos | FOXA1 HOXA2 PTPRG YAP1 GLUD2 CRYBG1 HS3ST2 MN1 KLK15 RAP1GAP HDAC5 SH3GL2 LAIR1 SLITRK3 RUNX3 TFAP2C TFE3 FARP1 DYRK1B MYOCD | 2.33e-05 | 724 | 218 | 20 | ctd:C012568 |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; HL60; HT_HG-U133A | 2.43e-05 | 200 | 218 | 10 | 2390_UP | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | CNKSR1 MAP4 TTLL5 TNRC6B MICALL1 BAZ2A IGHMBP2 SORBS3 ELK1 MARK2 | 2.43e-05 | 200 | 218 | 10 | 7182_DN |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; PC3; HT_HG-U133A | CNKSR1 BRD1 KDM6A RAP1GAP DZANK1 GTF3C2 ZNF592 RNFT1 RAPGEF2 MAP2K5 | 2.43e-05 | 200 | 218 | 10 | 7291_DN |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.18e-05 | 171 | 218 | 9 | 7535_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.78e-05 | 174 | 218 | 9 | 7530_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HG-U133A | 5.46e-05 | 177 | 218 | 9 | 1951_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.05e-05 | 189 | 218 | 9 | 5675_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 192 | 218 | 9 | 6054_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.06e-04 | 193 | 218 | 9 | 6678_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 4082_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 4331_DN | |
| Drug | paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A | 1.10e-04 | 194 | 218 | 9 | 640_DN | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 3680_UP | |
| Drug | butein; Down 200; 10uM; PC3; HG-U133A | 1.10e-04 | 194 | 218 | 9 | 582_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 4309_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 4492_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 5977_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 3298_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 5428_DN | |
| Drug | nocodazole; Up 200; 1uM; MCF7; HG-U133A | 1.15e-04 | 195 | 218 | 9 | 621_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 3099_UP | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 3047_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.15e-04 | 195 | 218 | 9 | 7351_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 7288_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 7277_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 7369_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 4296_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 3083_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 1820_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 5767_DN | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 4535_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 7367_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 6715_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; HL60; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 3123_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 5111_UP | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 3359_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; HL60; HG-U133A | MAP4 TOGARAM1 TULP4 NFE2L1 RAP1GAP RUNX3 VPS13D BAZ2A SNAPC4 | 1.19e-04 | 196 | 218 | 9 | 1716_DN |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | ZBTB20 MAML1 MED14 KDM6A DZANK1 PLEKHG6 IGHMBP2 SORBS3 MAP2K5 | 1.24e-04 | 197 | 218 | 9 | 3039_DN |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2728_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 4474_DN | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 6747_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 3692_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 1222_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 3056_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2643_DN | |
| Drug | SB 203580; Up 200; 1uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 7066_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2892_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 6934_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2324_DN | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 4577_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 4277_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 3730_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 6239_UP | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; MCF7; HT_HG-U133A | MAP4 TNRC6B TOGARAM1 SLC2A8 OGFR MICALL1 GTF3C2 FARP1 SAMD4A | 1.29e-04 | 198 | 218 | 9 | 5352_DN |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7189_DN | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 5104_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7017_UP | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 2085_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 6622_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 1503_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 7266_DN | |
| Drug | Parathion | FOXA1 HOXA2 PTPRG YAP1 GLUD2 CRYBG1 HS3ST2 MN1 KLK15 RAP1GAP HDAC5 SH3GL2 LAIR1 SLITRK3 RUNX3 TFAP2C TFE3 FARP1 DYRK1B MYOCD | 1.34e-04 | 822 | 218 | 20 | ctd:D010278 |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 4986_UP | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.77e-06 | 59 | 208 | 6 | EFO_0009658, GO_0009410 | |
| Disease | influenza A severity measurement | 2.81e-05 | 9 | 208 | 3 | EFO_0007743 | |
| Disease | platelet crit | ANKRD31 ZBTB20 ADGRV1 PMEPA1 PANK1 C2CD5 MAST4 TULP4 NFE2L1 EXOC3L4 PLCB1 RPRD2 MN1 WASL TTC28 ZNF407 HDAC7 DOT1L SAMD4A | 4.89e-05 | 952 | 208 | 19 | EFO_0007985 |
| Disease | alcohol consumption measurement | ANKS1B ADGRV1 FMNL2 BIRC6 MAGI2 MAST4 RPTOR PLCB1 RPRD2 HS3ST2 RASGRF2 MAGI3 POU2F2 RUNX1T1 MICALL1 ARSA FARP1 SNTG2 CIPC MAP2K5 ST18 AFF4 | 7.23e-05 | 1242 | 208 | 22 | EFO_0007878 |
| Disease | Malignant neoplasm of breast | XIRP1 MED14 FOXA1 ADAR SGK3 YAP1 PLCB1 DMD KLK15 RAP1GAP RARB WARS1 RASGRF2 TACC2 HDAC7 AKAP12 MICALL1 HEY1 FARP1 TNS1 | 7.99e-05 | 1074 | 208 | 20 | C0006142 |
| Disease | age at menarche | ZBTB20 DDN KCNB2 MAGI2 MFAP3 PTPRG RPTOR PLCB1 KISS1 TTC28 CRTC1 DZANK1 MAP2K5 ST18 | 9.03e-05 | 594 | 208 | 14 | EFO_0004703 |
| Disease | response to ketamine, dissociation measurement | 9.37e-05 | 13 | 208 | 3 | EFO_0009748, EFO_0009750 | |
| Disease | coronary artery disease | ANKRD31 ZBTB20 KCNB2 PMEPA1 AFAP1L2 MAST4 NFIB RPTOR RPRD2 TNS3 RGL3 DOK7 FBF1 RNF213 MAGI3 AKAP12 FARP1 KIAA1217 RAPGEF2 TNS1 PALLD | 1.17e-04 | 1194 | 208 | 21 | EFO_0001645 |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 1.21e-04 | 328 | 208 | 10 | EFO_0008377, EFO_0008378 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.48e-04 | 15 | 208 | 3 | EFO_0008208 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.48e-04 | 15 | 208 | 3 | C2930967 | |
| Disease | immune system disease (implicated_via_orthology) | 1.48e-04 | 3 | 208 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | Moyamoya disease | 1.80e-04 | 40 | 208 | 4 | MONDO_0016820 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ZBTB20 ADGRB2 BIRC6 TMEM71 MAGI2 TULP4 NFIB DLX6 RARB TTC28 RASGRF2 ZNF407 TACC2 RUNX1T1 PBX1 MAP2K5 | 1.94e-04 | 801 | 208 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | bacteriemia | 2.18e-04 | 17 | 208 | 3 | EFO_0003033 | |
| Disease | mean arterial pressure | MAP4 HM13 RPTOR POU2F3 WARS1 RGL3 RNF213 RUNX3 HDAC7 TFE3 KIAA1217 TNS1 | 2.40e-04 | 499 | 208 | 12 | EFO_0006340 |
| Disease | body weight | ANKS1B TNRC6B ADGRV1 KCNB2 SGK3 MFAP3 MAST4 PTPRG TULP4 DMD CACNA1B ZCCHC12 RARB SH3RF1 CRTC1 RUNX1T1 MAP7D1 KIAA1217 SP9 DOT1L MAP2K5 | 2.46e-04 | 1261 | 208 | 21 | EFO_0004338 |
| Disease | Hereditary Diffuse Gastric Cancer | 2.50e-04 | 293 | 208 | 9 | C1708349 | |
| Disease | Stomach Neoplasms | 2.77e-04 | 297 | 208 | 9 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 2.98e-04 | 300 | 208 | 9 | C0024623 | |
| Disease | obesity | 3.30e-04 | 241 | 208 | 8 | EFO_0001073 | |
| Disease | Autism Spectrum Disorders | 3.44e-04 | 85 | 208 | 5 | C1510586 | |
| Disease | severe acute respiratory syndrome, COVID-19 | TMPRSS13 MAGI2 JARID2 GLI2 MYO3B DMD CRTC1 MICALL1 ZFYVE28 KIAA1217 PBX1 | 3.58e-04 | 447 | 208 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | ovarian carcinoma | 4.86e-04 | 321 | 208 | 9 | EFO_0001075 | |
| Disease | post-operative atrial fibrillation, response to surgery | 4.88e-04 | 5 | 208 | 2 | EFO_0009951, EFO_0009952 | |
| Disease | Epithelioid hemangioendothelioma | 4.88e-04 | 5 | 208 | 2 | C0206732 | |
| Disease | Adenoid Cystic Carcinoma | 7.26e-04 | 100 | 208 | 5 | C0010606 | |
| Disease | Pituitary Hormone Deficiency, Combined, 1 | 7.28e-04 | 6 | 208 | 2 | C2751608 | |
| Disease | smoking behavior | ZBTB20 ADGRB2 NAV2 RARB RASGRF2 ZNF407 RUNX1T1 MICALL1 MAP2K5 | 7.48e-04 | 341 | 208 | 9 | EFO_0004318 |
| Disease | Paroxysmal atrial fibrillation | 8.63e-04 | 156 | 208 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 8.63e-04 | 156 | 208 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 8.63e-04 | 156 | 208 | 6 | C2585653 | |
| Disease | pulse pressure measurement | NEK10 TNRC6B FBXO38 YAP1 RPTOR ATAD2B BRD1 TNS3 TTC28 RGL3 RNF213 MEI1 ARHGEF25 KCNH4 KIAA1217 FAM53B DOT1L MBD5 ST18 PALLD SAMD4A | 8.88e-04 | 1392 | 208 | 21 | EFO_0005763 |
| Disease | age at diagnosis, type 1 diabetes mellitus | 9.72e-04 | 62 | 208 | 4 | EFO_0004918, MONDO_0005147 | |
| Disease | Atrial Fibrillation | 9.84e-04 | 160 | 208 | 6 | C0004238 | |
| Disease | susceptibility to rheumatic fever measurement | 9.93e-04 | 28 | 208 | 3 | EFO_0008416 | |
| Disease | retinal vasculature measurement | TTLL5 PRAG1 MYO3B PLCB1 RARB MUC12 FLVCR2 SNTG2 R3HDM1 TNS1 PALLD | 1.18e-03 | 517 | 208 | 11 | EFO_0010554 |
| Disease | Embryonal Rhabdomyosarcoma | 1.35e-03 | 8 | 208 | 2 | C0206656 | |
| Disease | allantoin measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0010456 | |
| Disease | Attached earlobe | 1.35e-03 | 8 | 208 | 2 | HP_0009907 | |
| Disease | chronotype measurement | TNRC6B KCNB2 PRAG1 BIRC6 MAGI2 PTPRG ATAD2B RPRD2 HS3ST2 RARB TTC28 POU2F2 RUNX1T1 R3HDM1 ST18 | 1.56e-03 | 882 | 208 | 15 | EFO_0008328 |
| Disease | urate measurement, bone density | UBE4B MAST4 PTPRG YAP1 GLI2 PLCB1 TTC28 MAGI3 CRTC1 AKAP12 HEATR6 PBX1 | 1.57e-03 | 619 | 208 | 12 | EFO_0003923, EFO_0004531 |
| Disease | response to methylphenidate | 1.72e-03 | 9 | 208 | 2 | GO_0036271 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.88e-03 | 74 | 208 | 4 | DOID:3748 (is_marker_for) | |
| Disease | oppositional defiant disorder measurement | 2.08e-03 | 36 | 208 | 3 | EFO_0007679 | |
| Disease | Muscle Weakness | 2.14e-03 | 10 | 208 | 2 | C0151786 | |
| Disease | Congenital myasthenic syndrome | 2.14e-03 | 10 | 208 | 2 | cv:C0751882 | |
| Disease | mosquito bite reaction itch intensity measurement | 2.25e-03 | 129 | 208 | 5 | EFO_0008377 | |
| Disease | aortic valve stenosis (is_marker_for) | 2.61e-03 | 11 | 208 | 2 | DOID:1712 (is_marker_for) | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 2.61e-03 | 11 | 208 | 2 | EFO_0009923 | |
| Disease | response to antihypertensive drug | 3.02e-03 | 41 | 208 | 3 | EFO_0005405 | |
| Disease | comparative body size at age 10, self-reported | 3.10e-03 | 420 | 208 | 9 | EFO_0009819 | |
| Disease | Neurobehavioral Manifestations | 3.12e-03 | 12 | 208 | 2 | C0525041 | |
| Disease | risk-taking behaviour | ZBTB20 BIRC6 PMEPA1 MAGI2 TULP4 ATAD2B CACNA1G RARB RASGRF2 RUNX1T1 FARP1 RP1L1 ST18 | 3.16e-03 | 764 | 208 | 13 | EFO_0008579 |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.30e-03 | 346 | 208 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 3.53e-03 | 88 | 208 | 4 | EFO_0803332 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement | 3.66e-03 | 13 | 208 | 2 | EFO_0000280, EFO_0000478, EFO_0008343 | |
| Disease | smoking status measurement | ZBTB20 ADGRB2 ANKS1B ADAR BIRC6 TMEM71 MAGI2 MFAP3 PTPRG TULP4 NAV2 TMEM200C RARB RASGRF2 ZNF407 RUNX1T1 MAP2K5 | 3.67e-03 | 1160 | 208 | 17 | EFO_0006527 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.94e-03 | 45 | 208 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | hemorrhoid | 3.95e-03 | 147 | 208 | 5 | EFO_0009552 | |
| Disease | nevus count, cutaneous melanoma | 3.97e-03 | 91 | 208 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | migraine disorder | 3.99e-03 | 357 | 208 | 8 | MONDO_0005277 | |
| Disease | photoreceptor cell layer thickness measurement | 4.06e-03 | 148 | 208 | 5 | EFO_0803370 | |
| Disease | testosterone measurement | ZBTB20 ANKS1B ADAR BIRC6 PMEPA1 FBXO38 PTPRG YAP1 PLCB1 KISS1 TNS3 TCF12 WARS1 TTC28 DOK7 GTF3C2 MYOCD PROX1 | 4.16e-03 | 1275 | 208 | 18 | EFO_0004908 |
| Disease | hypothyroidism | 4.17e-03 | 284 | 208 | 7 | EFO_0004705 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | triacylglycerol 46:2 measurement | 4.26e-03 | 14 | 208 | 2 | EFO_0010402 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 4.26e-03 | 14 | 208 | 2 | DOID:3969 (is_marker_for) | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 4.42e-03 | 216 | 208 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | electrocardiography | 4.58e-03 | 530 | 208 | 10 | EFO_0004327 | |
| Disease | response to olanzapine | 4.89e-03 | 15 | 208 | 2 | GO_0097333 | |
| Disease | osteoarthritis | 5.04e-03 | 222 | 208 | 6 | MONDO_0005178 | |
| Disease | colorectal cancer (is_marker_for) | 5.21e-03 | 157 | 208 | 5 | DOID:9256 (is_marker_for) | |
| Disease | decreased susceptibility to hepatitis C infection | 5.56e-03 | 16 | 208 | 2 | EFO_0010101 | |
| Disease | galectin-3 measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0008137 | |
| Disease | colorectal mucinous adenocarcinoma | 5.56e-03 | 16 | 208 | 2 | EFO_0009361 | |
| Disease | cortical thickness | VWA5B2 TNRC6B ADGRV1 FMNL2 ZNF469 MAST4 NAV2 TACC2 RUNX1T1 MICALL1 VPS13D EFNB2 FAM53B TMEM131 TNS1 ST18 | 5.73e-03 | 1113 | 208 | 16 | EFO_0004840 |
| Disease | mean platelet volume | MAST4 NFE2L1 EXOC3L4 ATAD2B PLCB1 BRD1 TCF12 HDAC5 TTC28 CRTC1 HDAC7 ARSA BAZ2A FAM53B PBX1 | 6.04e-03 | 1020 | 208 | 15 | EFO_0004584 |
| Disease | SLAM family member 7 measurement | 6.27e-03 | 17 | 208 | 2 | EFO_0008287 | |
| Disease | response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant | 6.27e-03 | 17 | 208 | 2 | EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276 | |
| Disease | S-adenosylhomocysteine measurement | 6.27e-03 | 17 | 208 | 2 | EFO_0010531 | |
| Disease | Metastatic melanoma | 6.58e-03 | 54 | 208 | 3 | C0278883 | |
| Disease | sphingosine 1-phosphate measurement | 7.02e-03 | 18 | 208 | 2 | EFO_0800185 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 7.02e-03 | 18 | 208 | 2 | EFO_1000649, HP_0000131 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 7.02e-03 | 18 | 208 | 2 | OBA_2045110 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPSSPNRTAEGGHQT | 626 | P23470 | |
| PAPPAEADLHSGSSN | 256 | O60241 | |
| LNDGPATGHSQATPE | 91 | Q17RC7 | |
| NEALPSAHGTPASAS | 101 | O95696 | |
| QASGSAHSTPNLGHP | 521 | O75150 | |
| TNGHSPSQPRDALGD | 131 | Q9Y2D5 | |
| QAGGHAASSPEISQP | 296 | P19419 | |
| AQGSTHTPINGSLPS | 511 | Q86VW2 | |
| GSSNGNPRVPHLSSA | 21 | Q92754 | |
| LSGTSPHGTNQHSPQ | 2766 | Q9NR09 | |
| HAGQEQPSPSNSGGL | 926 | Q86TB3 | |
| PTAHSPASSREGAGQ | 1171 | Q86TB3 | |
| GSQEHDPGQGSSSPE | 731 | Q02952 | |
| ILGGSRQPSSPSHNT | 126 | Q9UIF9 | |
| HLSGVQSSAPGGAQL | 4976 | Q8WXG9 | |
| FLHGPSSAQAQASSP | 546 | Q8N4X5 | |
| GGPASHSNPRSLSSG | 351 | Q9BYV8 | |
| TGSAGPAHPTNNFSS | 126 | Q8IY63 | |
| PLDSPSEGHSYQNSG | 301 | Q8N6T3 | |
| AINANSHGGPALSLP | 11 | O00213 | |
| TESSGLAQPEHGPNT | 181 | Q8N6H7 | |
| PNHPSSSGSFSDADL | 81 | P14209 | |
| GPASQHFLSTSVQGP | 3046 | P11532 | |
| SPAHQLSSSPRLGGA | 1001 | Q8TEK3 | |
| NSTSHQPATPGGDTA | 526 | Q9HBB8 | |
| GSPEHQALGPAASGA | 566 | O94850 | |
| HPQGSGSVNGSPLLS | 2161 | Q00975 | |
| GAGAAAPASQHPATG | 31 | Q14444 | |
| APASQHPATGTGAVQ | 36 | Q14444 | |
| GSNPHESDPLQGSAA | 111 | P56179 | |
| HQAPASASSLPGTGA | 526 | Q9Y463 | |
| VAPDLAGHGASSAPQ | 206 | Q96I13 | |
| TPGSNSEPSHHNSEG | 406 | Q9UHB7 | |
| SGQSAQLLSHEPGDP | 506 | Q8N1F7 | |
| HRDPEGSVSGSQPNS | 106 | Q14494 | |
| QPLPGTALSQSSHGA | 426 | Q15032 | |
| EQDSGQSGSPSHNDP | 186 | O00712 | |
| NSEGHEPLTPSSSGN | 416 | P10826 | |
| GHASPLAANGQSPSP | 281 | Q3YEC7 | |
| PLPSSGNEQHSSASI | 1451 | Q9HCM3 | |
| SQANFTLGPVSPSHG | 276 | Q8N149 | |
| PSAHEAPQALSGSSS | 671 | Q9HCC9 | |
| GTSNHRNSSTGPTPD | 491 | Q7Z6G8 | |
| NLEHPQSGSLSPVSG | 1466 | Q8N7Z5 | |
| LADSSLHLNGGSNPS | 191 | Q92585 | |
| GPGGASELSSAHQLQ | 386 | Q92585 | |
| VSAHGSQANSPSTPN | 316 | P40424 | |
| AAVPAPRLSGSNHSG | 91 | Q9Y278 | |
| GQKGESPNSFHGPSS | 86 | A8MXT2 | |
| AGAPTSASGLNGHPT | 1116 | P27816 | |
| SNHAAPSSNASPPEG | 896 | Q86UL8 | |
| HGPPSGTNSARQSPA | 941 | Q5TCQ9 | |
| GSQQSPDGTQLPSGH | 81 | P13196 | |
| LTNGTSHSPTALNGA | 76 | Q06455 | |
| NSTHTRPPGASGSAL | 56 | Q9BVV8 | |
| SQPGATLPNGHSGLS | 126 | Q9ULI0 | |
| HSASGSGTSSPLNQP | 1616 | Q2KJY2 | |
| SLHDALSGSGNPNPQ | 6 | P17931 | |
| SSAGPTQRPSDNSHN | 136 | Q6GTX8 | |
| GTAPATQHSQAGPAT | 186 | Q96PV6 | |
| GQSSHSAGPNGERPL | 646 | O15550 | |
| GHPTLPSNSVTQGAA | 681 | O15550 | |
| KPNPGSSTDGNSAGH | 201 | P52799 | |
| LSISDHNGNPSAPPS | 96 | Q14153 | |
| HRSSGGNSLSPNDPT | 1106 | Q6ZWH5 | |
| VSHNEPGTAGSPRSQ | 146 | Q9H2R5 | |
| AGPSQHSSPAVSDSL | 126 | Q13163 | |
| LGPSHNAPIGSLNSN | 436 | Q99081 | |
| LGNSNSATPHLSPPD | 611 | Q6AI08 | |
| TNPSPQGSHSAIGLS | 446 | P09086 | |
| QGSHSAIGLSGLNPS | 451 | P09086 | |
| LSNGSVPGFRQSHSP | 616 | Q9P1Y6 | |
| ESSGSPQQPGLSAPH | 76 | Q15726 | |
| SLSPALAGQGHSASP | 781 | Q9UQ05 | |
| SSSEPAVHAPGTPGN | 536 | Q8N3F8 | |
| SEASPLGAGRPHNAS | 836 | P10070 | |
| SDPHNGSAEAGGPTN | 6 | Q8TCT9 | |
| THGKNSLNSGQGPSP | 1131 | P00451 | |
| HPSSTTPNLDQLAAG | 41 | P15289 | |
| LSSAQSAPLQHPGGF | 1406 | Q9UKK3 | |
| GGSQAPSPIANTFLH | 46 | Q3MIN7 | |
| NGRNFGNSHPPTKGS | 46 | Q9H422 | |
| PGIPQSNSGVSTLHG | 306 | P52952 | |
| GNNSRPSSPGSGLHA | 386 | Q9UKI9 | |
| GPQETLQAAGPTSHD | 276 | Q6ZMM2 | |
| NNPHFLPSSSGAQGE | 656 | Q8IZQ8 | |
| SDAPPGGDLAASQNH | 91 | D6RGH6 | |
| SQGSSHFSPPDDIGS | 331 | P55082 | |
| GSSFQHQQSSGPPSL | 241 | Q969W9 | |
| TQSPGNLHAASSPSG | 1041 | O60244 | |
| EHGASPSGASGNLPL | 896 | Q5TIA1 | |
| QNLGPASGHGTPASS | 741 | Q8WX93 | |
| HSGSPAAAVNGNQPS | 276 | Q9BRQ0 | |
| RGQLPSSPTHADSAG | 691 | Q3KR16 | |
| PQGGSSGPAHDERTN | 821 | Q6PIJ6 | |
| DPSGASNPSADSPLH | 296 | P55317 | |
| GHPQASPGAASAENG | 341 | Q6PI47 | |
| SPGAASAENGGTHLP | 346 | Q6PI47 | |
| QLGQPSSTGPSNSEH | 46 | Q6UXA7 | |
| SHAPSGAPGQEASHT | 116 | Q658K8 | |
| AASETLSGHGPLAQP | 766 | O75173 | |
| PGVSGSPVTQNHAAS | 491 | Q8TES7 | |
| GLHSPLQSDNATDSP | 686 | Q92953 | |
| RPDSHSQGSPNSDPG | 261 | P55265 | |
| DSGSQPHLGTDPSNL | 2276 | O43497 | |
| GLTGSHGSLPDSQQL | 536 | Q6UUV9 | |
| GSPHLSELSVNSQGG | 476 | Q9Y4F1 | |
| SSTNLHSPNPSDDGA | 221 | Q9BQY9 | |
| SPGPEAHQGFSRQLS | 396 | Q6UUV7 | |
| QPHGHSPSSQSRGQS | 1181 | Q5JV73 | |
| SAASTDASHPGASQP | 341 | Q6RFH8 | |
| NGSRFPDSTGTPAHS | 46 | P51993 | |
| SSAHPSALAQPSGLA | 51 | Q9UPI3 | |
| HRGSNLPSPVGNSVS | 176 | Q96PY5 | |
| PVASPSAHNISSSGG | 566 | Q7KZI7 | |
| LPAHQENGFSTNGPS | 791 | Q3KQU3 | |
| SPSSSAPNSPAGSGH | 1331 | O15021 | |
| TRSNPGFHGAPNSSP | 251 | Q9P267 | |
| LPQNGHGNAGTTASP | 196 | Q9Y5J3 | |
| ESSPTNSPSSGNHLA | 646 | Q9Y4K1 | |
| RDHSPPSQGSPGNSA | 416 | Q18PE1 | |
| AHHASLDQSSPPQSG | 216 | Q9UQL6 | |
| ASGCSSPNDSEHGPN | 206 | Q8WUI4 | |
| PTRQSQSPGFAHVSG | 176 | Q9NVP4 | |
| VPSERGLSPNNSGHD | 371 | Q9UKT9 | |
| SNSSSGPPLGPSHRD | 1391 | Q5VT52 | |
| HSTSQNINLGPSGNP | 141 | Q96BR1 | |
| GPGPSVQHTTLNGDS | 661 | Q9BXL7 | |
| NEDPNPNTHSSGPST | 271 | Q86YS7 | |
| PSRAGPAALGSAANH | 11 | P49448 | |
| AENTSGGDHPSTQGP | 256 | Q53GL7 | |
| SANHPAAAPSTGSSA | 266 | Q92833 | |
| HSPGAPVGTSAAAVN | 151 | Q8TE04 | |
| APNGHNGDSQSFPVS | 261 | O43364 | |
| AQTLALAGSPAPSGH | 476 | Q9NZT2 | |
| AGRQSTPHSGPGVNS | 751 | Q10571 | |
| AQLSDSQHGSPPAAS | 271 | Q96JB3 | |
| DGSHSNSPTALSTPG | 391 | Q13761 | |
| NPAPTSNHGPDATEA | 66 | P23381 | |
| GSPSQASPTLGAFTH | 381 | C9JL84 | |
| SPGANSASLPGHPNK | 6 | Q9H0F5 | |
| QPPGGNSHSLSLQSQ | 196 | Q6P5X7 | |
| GHENGNSSSPSPEEK | 1781 | P35499 | |
| HPRAPGGVNSSSAGA | 116 | A6NKL6 | |
| ASHSSGQRTPQGPVS | 1086 | O15061 | |
| GSINSSLPHGEGSLQ | 36 | Q6ZUX3 | |
| TAAAGHGSPPGFNNT | 886 | O14827 | |
| GPGNSSHVAISAPVS | 346 | Q9NY64 | |
| NSSDQSASGPAAGGH | 446 | Q92786 | |
| QPGDSHLIGAPTSAS | 626 | O94933 | |
| SHSAGGLQDTAANSP | 1536 | Q8IVL1 | |
| STSHSGSFAPNNPDL | 456 | P47736 | |
| SQPHSLATETRNPGG | 1521 | Q5T5P2 | |
| FGHPQPGSANSLSAS | 106 | Q8IYI0 | |
| DALGLSGNDTPGPSH | 506 | Q2M3G4 | |
| SGNDTPGPSHNTALA | 511 | Q2M3G4 | |
| PGPSHNTALARGTGQ | 516 | Q2M3G4 | |
| SINLVGSSGHLQSPG | 106 | Q2M3A8 | |
| SLHGLAAGAPPQDSS | 86 | O95096 | |
| SPLFDSGLHLNGNSS | 181 | Q9NY99 | |
| LSSSEGPQSAHLGPF | 496 | Q68CZ2 | |
| ATEQPGSLHSSQGLG | 336 | Q13546 | |
| PAGGLQSSLHSGAPQ | 196 | P0CG40 | |
| GAPASPSASHPQGLD | 926 | P98171 | |
| IHQAGGSPPASSTSS | 871 | Q8N122 | |
| QNAAGLSPASVGLSH | 611 | Q7Z6J0 | |
| PSAGAHTQSPGRASS | 546 | O60284 | |
| GVPTSQAESHSGPLN | 4836 | Q8IVF2 | |
| ASHSPFQPQTTGGSA | 261 | P52594 | |
| AGGSPQTLQPVSSSH | 236 | Q9C0C6 | |
| AGSHSASPSPAQAGS | 531 | Q969H4 | |
| ASPSPAQAGSPLHGD | 536 | Q969H4 | |
| AQAGSPLHGDTSPAA | 541 | Q969H4 | |
| ASGRPHGNTTASTAP | 96 | Q9H7T3 | |
| SSDTAGPSSVQQPHG | 1441 | Q9Y4G8 | |
| TALPHSQAQQSGPTG | 131 | Q63HN8 | |
| AGVRPSAGNVSTHPS | 31 | O43493 | |
| SGTGPSSQPGASLAH | 1041 | Q9NRJ4 | |
| AQVPSAHQPSASGGA | 51 | Q8NHG8 | |
| NRSQLHSPPGTGSSE | 41 | Q5M7Z0 | |
| LHSHSGALDGSPNTP | 361 | Q9UN79 | |
| SLPFTDPASGGQSQH | 101 | Q8N9X5 | |
| THFQNPGNTRLGSSP | 71 | Q9NUR3 | |
| GATSSFENGHPSQPG | 566 | O15062 | |
| HGNASPARTPSAGAS | 6 | Q9BYE2 | |
| GESPLAFLTSNPGHS | 951 | Q13009 | |
| PEAAHTTGPTGSAPN | 231 | P19532 | |
| SHSPGDSSAPIQNTD | 1626 | Q13129 | |
| SLQLSGHAQGPSQGP | 2251 | Q15772 | |
| SHQSTARGPGGSPQE | 876 | Q8IWN7 | |
| TQASSHNPGEPGRLA | 151 | Q9BW04 | |
| DHAPLSPQSSVASSG | 266 | Q5PRF9 | |
| PTGDSTQPNGGLSHT | 266 | Q99962 | |
| SQGSSHAATKPQGPA | 656 | P38935 | |
| TETTPSPSNDTGNGH | 41 | Q8IUW5 | |
| DSLGHTNPLAASSPA | 101 | A6NCQ9 | |
| SPHSAASGTAAGSQP | 311 | O95155 | |
| HFPEAGTNSGSPQGA | 431 | Q92610 | |
| AGPSPGTSLGLAQQH | 6 | A6NH21 | |
| HAPSTSSPADDLGQT | 1841 | Q92545 | |
| GNLASGLHSNAIASP | 1281 | Q9HBL0 | |
| GLHSNAIASPGSPSL | 1286 | Q9HBL0 | |
| HSSPASLQLGAVSPG | 126 | P46937 | |
| QNLGTPGPALSHSRG | 581 | O60504 | |
| QAHLASSPPSSQAPG | 566 | P78364 | |
| GPHSQTAEADASGLP | 646 | O95359 | |
| NESGPSNSTNPNSHG | 576 | Q04864 | |
| SDGGPSSELAHSPTN | 771 | Q86YV5 | |
| PSQPSTGGAFALSHQ | 176 | O75360 | |
| DSNHGSAPLSLSSDP | 1176 | Q9NQ66 | |
| VALHSASNGTPPAGT | 681 | Q9HC78 | |
| GPGGTQAPVSHNSKD | 1276 | Q96JG9 | |
| PGGTDNHASVNASPK | 1981 | Q96JG9 | |
| VPDSNSSSPNHQGDG | 341 | Q9NZI7 | |
| GHQSPAGSAPSPALS | 2311 | Q96AY4 | |
| SPDPGQANNSEGSDH | 1041 | Q8N398 | |
| ASSNAPGPRPSSGSH | 651 | Q9ULC8 | |
| PTHALSQSPAEADGS | 1156 | Q5SXM2 | |
| PEGPDHSSASSGVPN | 766 | Q8WUA4 | |
| QGQGSARPPDSGLHS | 501 | Q9C0G0 | |
| LPSDGDHQVPTTAGN | 391 | O00401 | |
| HIAEQSPSAGSSSNP | 1071 | Q9Y4F4 | |
| SQGEPSGHREAANSP | 141 | Q9BZD7 | |
| EGSHQGAPESPDSLQ | 1451 | Q702N8 | |
| ATPSAGASGGLQPHQ | 461 | Q9UPU9 | |
| PQAPENHSSSPGSRS | 1096 | Q6EMB2 | |
| PHNSRAQFPSTSGGS | 311 | Q6PEW1 | |
| SGASSNNGTSPNPIH | 171 | Q9UPQ9 | |
| LHLPGSSDSPASASQ | 21 | Q5H9K5 | |
| QSPVSGPNVAHLTDG | 1041 | Q5THJ4 | |
| PGLSQESTASHSSPG | 686 | Q9UKN1 | |
| TSNQSSGPHSPVAAG | 1126 | Q8WXR4 | |
| SSAFPASPKQHAGSN | 66 | Q9UBF9 |